GOID	Ontology Source	GOTerm	GOLevels	GOGroups	Nr. Genes	% Associated Genes	Term PValue	Term PValue Corrected with Bonferroni step down	Group PValue	Group PValue Corrected with Bonferroni step down	Associated Genes Found	All Associated Genes	OverViewTerm
WP:3	WikiPathways_09.11.2015	Transcriptional activation by NRF2	[-1]	[Group19, Group22, Group36, Group66, Group70]	1	6.6666665	0.16271498944031434	1.0	{Group19=1.0, Group22=0.11196305953800512, Group36=0.4341567002016995, Group66=0.09528179928216532, Group70=0.37553683169036156}	{Group19=1.0, Group22=1.0, Group36=1.0, Group66=1.0, Group70=1.0}	[PIK3CA]	[AIMP2, CEBPB, EPHB2, GCLC, GCLM, GSTA2, HMOX1, KEAP1, MAF, MAPK8, NFE2L2, NQO1, PIK3CA, PRKCA, SLC7A11]	TRUE
WP:23	WikiPathways_09.11.2015	B Cell Receptor Signaling Pathway	[-1]	[Group1, Group12, Group21, Group33, Group34, Group41, Group46, Group47]	3	3.0927835	0.10486357463728843	1.0	{Group1=0.3422234010584369, Group12=0.2420215438602354, Group21=0.060782830193602554, Group33=0.013749297939086429, Group34=0.023242299876161884, Group41=0.11610019037275422, Group46=0.013359738966869447, Group47=0.005968472152834779}	{Group1=1.0, Group12=1.0, Group21=1.0, Group33=0.57747051344163, Group34=0.9296919950464754, Group41=1.0, Group46=0.5744687755753862, Group47=0.26858124687756507}	[BCL10, CREB1, HRAS]	[AKT1, ATF2, BCL10, BCL6, BLK, BLNK, BRAF, BTK, CAMK2A, CARD11, CBL, CD19, CD22, CD79A, CD79B, CD81, CDC42, CHUK, CR2, CREB1, CRK, CRKL, DAPP1, E2F3, ELK1, ETS1, FOXO1, FYN, GAB1, GAB2, GRB2, GSK3A, GSK3B, GTF2I, HCLS1, HRAS, IKBKB, IKBKG, ILF2, INPP5D, IRF4, JUN, KLF11, LAT2, LCK, LYN, MALT1, MAP2K1, MAP2K2, MAP2K6, MAP3K7, MAP4K1, MAPK1, MAPK14, MAPK4, MAPK8, MAPK9, MAX, MEF2C, MEF2D, MYC, NCK1, NFATC2, NFATC3, NFKB1, NFKBIA, PDPK1, PIK3AP1, PIK3CG, PIK3R1, PIK3R2, PIP5K1A, PIP5K1B, PIP5K1C, PLCG1, PLCG2, PRKCB, PRKCD, PTPN11, PTPN18, PTPN6, PTPRC, RAC1, RAC2, RAF1, RAPGEF1, RASGRP3, REL, RELA, RPS6KA1, SH3BP2, SHC1, SOS1, SYK, TEC, VAV1, VAV2]	TRUE
WP:34	WikiPathways_09.11.2015	Ovarian Infertility Genes	[-1]	[Group25, Group6, Group61, Group69]	1	3.125	0.3158180874997565	1.0	{Group25=0.0014192920911883721, Group6=0.0018572031677458632, Group61=3.758262700808551E-9, Group69=0.006439583968393921}	{Group25=0.0766417729241721, Group6=0.09843176789053075, Group61=2.518036009541729E-7, Group69=0.2833416946093325}	[ATM]	[ATM, BMPR1B, CCND2, CDK4, CDKN1B, CEBPB, CYP19A1, DAZL, DMC1, EGR1, ESR2, FIGLA, FSHR, GDF9, GJA4, INHA, LHCGR, MLH1, MSH5, NCOR1, NR5A1, NRIP1, PGR, PRLR, PTGER2, SMAD3, SMPD1, SYNE2, TBP, VDR, ZP2, ZP3]	FALSE
WP:35	WikiPathways_09.11.2015	G Protein Signaling Pathways	[-1]	[Group18, Group20, Group37, Group53, Group57, Group68, Group74]	4	4.255319	0.023910609410357112	1.0	{Group18=2.2676648782666833E-5, Group20=4.853337156445499E-4, Group37=7.113870981722735E-7, Group53=6.567096321826248E-4, Group57=2.7626465873397032E-5, Group68=3.328030031465086E-4, Group74=0.5483333906310934}	{Group18=0.0014059522245253437, Group20=0.028149355507383896, Group37=4.624016138119778E-5, Group53=0.036119029770044365, Group57=0.001685214418277219, Group68=0.01963537718564401, Group74=1.0}	[HRAS, KRAS, NRAS, PPP3CA]	[ADCY1, ADCY2, ADCY3, ADCY4, ADCY5, ADCY6, ADCY7, ADCY8, ADCY9, AKAP1, AKAP10, AKAP11, AKAP12, AKAP13, AKAP2, AKAP3, AKAP4, AKAP5, AKAP6, AKAP7, AKAP8, AKAP9, ARHGEF1, CALM1, GNA11, GNA12, GNA13, GNA14, GNA15, GNAI1, GNAI2, GNAI3, GNAL, GNAO1, GNAQ, GNAS, GNAZ, GNB1, GNB2, GNB3, GNB5, GNG10, GNG11, GNG12, GNG13, GNG3, GNG4, GNG5, GNG7, GNG8, GNGT1, GNGT2, HRAS, ITPR1, KCNJ3, KRAS, LOC100505585, LOC729966, NRAS, PDE1A, PDE1B, PDE1C, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B, PLCB3, PPP3CA, PPP3CC, PRKACA, PRKACB, PRKACG, PRKAR1A, PRKAR1B, PRKAR2A, PRKAR2B, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PRKCH, PRKCI, PRKCQ, PRKCZ, PRKD1, PRKD3, RHOA, RRAS, SLC9A1]	FALSE
WP:43	WikiPathways_09.11.2015	Oxidation by Cytochrome P450	[-1]	[Group24]	1	1.5873016	0.5274578106508484	1.0	{Group24=0.7890042018472335}	{Group24=1.0}	[CYP2D6]	[CYB5A, CYB5B, CYB5R1, CYB5R2, CYB5R3, CYB5R4, CYP11A1, CYP11B1, CYP11B2, CYP17A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP20A1, CYP24A1, CYP26A1, CYP26B1, CYP26C1, CYP27A1, CYP27B1, CYP27C1, CYP2A13, CYP2A6, CYP2A7, CYP2B6, CYP2C18, CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP2E1, CYP2F1, CYP2G1P, CYP2J2, CYP2R1, CYP2S1, CYP2U1, CYP2W1, CYP39A1, CYP3A4, CYP3A43, CYP3A5, CYP3A7, CYP3A7-CYP3A51P, CYP46A1, CYP4A11, CYP4A22, CYP4B1, CYP4F11, CYP4F12, CYP4F2, CYP4F22, CYP4F3, CYP4F8, CYP4V2, CYP4X1, CYP4Z1, CYP51A1, CYP7A1, CYP7B1, CYP8B1, POR]	FALSE
WP:45	WikiPathways_09.11.2015	G1 to S cell cycle control	[-1]	[Group21, Group6, Group69]	3	4.4117646	0.04506507094060386	1.0	{Group21=0.060782830193602554, Group6=0.0018572031677458632, Group69=0.006439583968393921}	{Group21=1.0, Group6=0.09843176789053075, Group69=0.2833416946093325}	[ATM, CREB1, POLE]	[ATF6B, ATM, CCNA1, CCNB1, CCND1, CCND2, CCND3, CCNE1, CCNE2, CCNG2, CCNH, CDC25A, CDC45, CDK1, CDK2, CDK4, CDK6, CDK7, CDKN1A, CDKN1B, CDKN1C, CDKN2A, CDKN2B, CDKN2C, CDKN2D, CREB1, CREB3, CREB3L1, CREB3L3, CREB3L4, E2F1, E2F2, E2F3, E2F4, E2F5, E2F6, GADD45A, MCM2, MCM3, MCM4, MCM5, MCM6, MCM7, MDM2, MNAT1, MYC, MYT1, ORC1, ORC2, ORC3, ORC4, ORC5, ORC6, PCNA, POLA2, POLE, POLE2, PRIM1, PRIM2, RB1, RBL1, RPA1, RPA2, RPA3, TFDP1, TFDP2, TP53, WEE1]	FALSE
WP:47	WikiPathways_09.11.2015	Hedgehog Signaling Pathway	[-1]	[Group8]	1	6.25	0.17258577446938866	1.0	{Group8=1.0}	{Group8=1.0}	[SMO]	[ADRBK1, ARNTL, DHH, GLI1, GLI2, GLI3, IHH, KIF7, PTCH1, PTCH2, SAP18, SHH, SIN3A, SMO, STK36, SUFU]	FALSE
WP:49	WikiPathways_09.11.2015	IL-2 Signaling Pathway	[-1]	[Group1, Group12, Group20, Group27, Group41, Group48]	1	2.3809524	0.392653099653618	1.0	{Group1=0.3422234010584369, Group12=0.2420215438602354, Group20=4.853337156445499E-4, Group27=0.003150245716997155, Group41=0.11610019037275422, Group48=0.10903713332925667}	{Group1=1.0, Group12=1.0, Group20=0.028149355507383896, Group27=0.15751228584985774, Group41=1.0, Group48=1.0}	[HRAS]	[AKT1, BCL2, CBL, CCND2, CISH, CRKL, FOS, FOXO3, FYN, GAB2, GRB2, HRAS, IL2, IL2RA, IL2RB, IL2RG, JAK1, JAK3, JUN, LCK, MAP2K1, MAP2K2, MAPK1, MAPK3, MAPT, MYC, NMI, PIK3R1, PTK2B, PTPN11, RAF1, RPS6, RPS6KB1, RPS6KB2, SHC1, SOCS3, SOS1, STAT1, STAT3, STAT5A, STAT5B, SYK]	FALSE
WP:51	WikiPathways_09.11.2015	Regulation of Actin Cytoskeleton	[-1]	[Group11, Group18, Group20, Group53, Group68, Group70, Group74]	5	3.3333333	0.030496094886829087	1.0	{Group11=0.0020227372439293166, Group18=2.2676648782666833E-5, Group20=4.853337156445499E-4, Group53=6.567096321826248E-4, Group68=3.328030031465086E-4, Group70=0.37553683169036156, Group74=0.5483333906310934}	{Group11=0.10518233668432446, Group18=0.0014059522245253437, Group20=0.028149355507383896, Group53=0.036119029770044365, Group68=0.01963537718564401, Group70=1.0, Group74=1.0}	[KRAS, NRAS, PIK3C3, PIK3CA, PTK2]	[ABI2, ACTB, ACTG1, ACTN1, APC, APC2, ARHGAP35, ARHGEF1, ARHGEF4, ARHGEF6, ARHGEF7, ARPC5, BAIAP2, BCAR1, BDKRB1, BDKRB2, BRAF, BRK1, CD14, CDC42, CFL1, CFL2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CRK, CSK, CYFIP2, DIAPH1, DIAPH3, DOCK1, EGF, EGFR, ENAH, EZR, F2, F2R, FGD1, FGF1, FGF10, FGF11, FGF12, FGF13, FGF14, FGF16, FGF17, FGF18, FGF19, FGF2, FGF20, FGF21, FGF22, FGF23, FGF3, FGF4, FGF5, FGF6, FGF7, FGF8, FGF9, FGFR1, FGFR2, FGFR3, FGFR4, FN1, GIT1, GNA12, GNA13, GNG12, GSN, IQGAP1, ITGA1, KRAS, LIMK1, LOC100505585, MAP2K1, MAP2K2, MAPK1, MAPK3, MAPK4, MAPK6, MOS, MRAS, MSN, MYH10, MYL1, MYL3, MYLK, NCKAP1, NRAS, PAK1, PAK2, PAK3, PAK4, PAK6, PAK7, PDGFA, PDGFB, PDGFRA, PDGFRB, PFN1, PIK3C2A, PIK3C2B, PIK3C2G, PIK3C3, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PIK3R3, PIK3R4, PIK3R5, PIP4K2A, PIP4K2B, PIP4K2C, PIP5K1A, PIP5K1B, PIP5K1C, PIP5KL1, PPP1R12A, PTK2, PXN, RAC1, RAC2, RAC3, RAF1, RASSF7, RDX, RHOA, ROCK1, ROCK2, RRAS, RRAS2, SLC9A1, SOS1, SOS2, SSH1, SSH2, SSH3, TMSB4X, VAV1, VCL, VIL1, WAS, WASF1, WASF2]	FALSE
WP:69	WikiPathways_09.11.2015	TCR Signaling Pathway	[-1]	[Group1, Group12, Group21, Group33, Group34, Group41, Group46, Group47]	3	3.3333333	0.08839188616253484	1.0	{Group1=0.3422234010584369, Group12=0.2420215438602354, Group21=0.060782830193602554, Group33=0.013749297939086429, Group34=0.023242299876161884, Group41=0.11610019037275422, Group46=0.013359738966869447, Group47=0.005968472152834779}	{Group1=1.0, Group12=1.0, Group21=1.0, Group33=0.57747051344163, Group34=0.9296919950464754, Group41=1.0, Group46=0.5744687755753862, Group47=0.26858124687756507}	[BCL10, CREB1, HRAS]	[AKT1, ATF2, BCL10, CARD11, CBL, CBLB, CCR5, CD247, CD28, CD3D, CD3E, CD3G, CD4, CD83, CD8A, CDC42, CHUK, CREB1, CRK, CRKL, DBNL, FAS, FOS, FYB, FYN, GAB2, GATA3, GRAP2, GRB2, HRAS, ICOS, IKBKB, IKBKG, IL15RA, IL17A, IL1A, IL1B, IL6, IL9, IRF4, ITK, ITPR1, JUN, LAT, LCP2, LHB, MALT1, MAP2K1, MAP2K2, MAP3K14, MAP3K7, MAP3K8, MAP4K1, MAPK1, MAPK14, MAPK3, MAPK8, MAPK9, NCK1, NFATC1, NFATC2, NFKB1, NFKBIA, OPRM1, PAK1, PDPK1, PIK3R1, PIK3R2, PLCG1, PRKCD, PRKCQ, PSTPIP1, PTK2B, PTPN11, RAF1, REL, RELA, RIPK2, SH2B3, SHC1, SKAP1, SOS1, TGFB1, TNFRSF9, TRAF6, VAV1, VAV3, VIM, WAS, ZAP70]	FALSE
WP:75	WikiPathways_09.11.2015	Toll-like receptor signaling pathway	[-1]	[Group19, Group22, Group36, Group66, Group70]	1	0.98039216	1.0	1.0	{Group19=1.0, Group22=0.11196305953800512, Group36=0.4341567002016995, Group66=0.09528179928216532, Group70=0.37553683169036156}	{Group19=1.0, Group22=1.0, Group36=1.0, Group66=1.0, Group70=1.0}	[PIK3CA]	[AKT1, AKT2, AKT3, CASP8, CCL3, CCL4, CCL5, CD14, CD40, CD80, CD86, CHUK, CXCL10, CXCL11, CXCL8, CXCL9, FADD, FOS, IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8, IFNAR1, IFNAR2, IFNB1, IKBKB, IKBKE, IKBKG, IL12A, IL12B, IL1B, IL6, IRAK1, IRAK4, IRF3, IRF5, IRF7, JUN, LBP, LY96, MAP2K1, MAP2K2, MAP2K3, MAP2K4, MAP2K6, MAP2K7, MAP3K7, MAP3K8, MAPK1, MAPK10, MAPK11, MAPK12, MAPK13, MAPK14, MAPK3, MAPK8, MAPK9, MYD88, NFKB1, NFKB2, NFKBIA, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PIK3R3, PIK3R5, RAC1, RELA, RIPK1, SPP1, STAT1, TAB1, TAB2, TBK1, TICAM1, TICAM2, TIRAP, TLR1, TLR2, TLR3, TLR4, TLR5, TLR6, TLR7, TLR8, TLR9, TNF, TOLLIP, TRAF3, TRAF6]	FALSE
WP:117	WikiPathways_09.11.2015	GPCRs, Other	[-1]	[Group8]	1	1.0752689	1.0	1.0	{Group8=1.0}	{Group8=1.0}	[SMO]	[ACKR1, ADGRD1, ADGRE2, ADGRE3, ADGRF5, ADGRG1, ADGRL2, ADGRL3, ADGRV1, ADORA2A, ADORA3, ADRA1D, ADRB2, ALG6, C5AR2, CCKBR, CCR5, CELSR1, CELSR2, CELSR3, CHRM2, CHRM3, CNR1, CXCR1, CXCR2, CXCR3, DRD3, DRD4, EDNRA, F2R, FSHR, GHRHR, GNRHR, GPR132, GPR135, GPR143, GPR162, GPR17, GPR176, GPR18, GPR183, GPR55, GPR61, GPR62, GPR83, GPR84, GPR88, GRM1, GRM8, GRPR, HRH4, HTR1F, HTR2A, HTR7, LGR6, LTB4R2, MCHR2, NTSR1, OR10A2, OR10A5, OR1E1, OR1F1, OR1G1, OR1N1, OR2A20P, OR2A4, OR2A5, OR2B6, OR2F1, OR2H1, OR2M4, OR3A1, OR3A3, OR5AC2, OR6C2, OR6C3, OR7E24, OR8G1, P2RY11, P2RY13, PROKR2, PTGFR, RXFP1, RXFP3, S1PR1, SMO, SSTR2, TAAR2, TAAR3, TAAR5, TMIGD3, UTS2R, VN1R1]	TRUE
WP:127	WikiPathways_09.11.2015	IL-5 Signaling Pathway	[-1]	[Group20, Group74]	1	2.5	0.37799707562739987	1.0	{Group20=4.853337156445499E-4, Group74=0.5483333906310934}	{Group20=0.028149355507383896, Group74=1.0}	[KRAS]	[AKT1, BCL2, BTK, CSF2RB, ELK1, FOS, FOXO3, GRB2, GSK3A, GSK3B, IL2, IL5RA, JAK1, JAK2, JUN, KRAS, LYN, MAP2K1, MAP2K2, MAPK1, MAPK3, MAPT, MYC, PIK3CG, PIK3R1, PIK3R2, PTPN11, RAF1, RPS6, RPS6KA1, RPS6KB1, RPS6KB2, SHC1, SOS1, SPRED1, STAT1, STAT3, STAT5A, STAT5B, SYK]	TRUE
WP:138	WikiPathways_09.11.2015	Androgen receptor signaling pathway	[-1]	[Group26, Group4, Group42, Group64]	4	4.494382	0.019985905051029186	1.0	{Group26=1.6750572661729398E-4, Group4=2.3359082094591414E-6, Group42=0.09746363511951099, Group64=1.3778632235359839E-5}	{Group26=0.010050343597037638, Group4=1.4949812540538505E-4, Group42=1.0, Group64=8.680538308276698E-4}	[BRCA1, CREB1, PTEN, PTK2]	[AES, AKT1, AR, BAG1, BMF, BRCA1, CALR, CARM1, CAV1, CCND1, CCNE1, CDC42, CDKN1A, CREB1, CREBBP, CTNNB1, DAXX, DSTN, EFCAB6, EGFR, EP300, ETV5, FHL2, FKBP4, FLNA, FOXO1, GNB2L1, GSK3B, HDAC1, JUN, KAT2B, KAT5, KAT7, KDM1A, KLK3, LIMK2, MDM2, NCOA1, NCOA2, NCOA3, NCOA4, NCOR1, NCOR2, NR0B2, NR2C2, PAK6, PARK7, PATZ1, PIAS1, PIAS2, PIAS3, PIAS4, PIK3R1, PIK3R2, PLPP1, PRDX1, PSMC3IP, PTEN, PTK2, RAC1, RAD9A, RAN, RB1, RELA, RHOA, RHOB, RLN1, RNF14, RNF4, RNF6, ROCK1, ROCK2, RUNX2, SIN3A, SIRT1, SMAD3, SMAD4, SMARCE1, SP1, SRC, STAT3, STUB1, SUMO1, TGFB1I1, TGIF1, UBE2I, UBE3A, ZMIZ1, ZNF318]	TRUE
WP:170	WikiPathways_09.11.2015	Nuclear Receptors	[-1]	[Group31, Group43, Group58, Group63]	1	2.631579	0.36299373532642165	1.0	{Group31=0.18555280111792985, Group43=0.27638591509599, Group58=0.04294071628232707, Group63=0.296656766532177}	{Group31=1.0, Group43=1.0, Group58=1.0, Group63=1.0}	[PPARA]	[AR, ESR1, ESR2, ESRRA, ESRRB, HNF4A, NR0B1, NR1D2, NR1H2, NR1H3, NR1I2, NR1I3, NR2C2, NR2E1, NR2F1, NR2F2, NR2F6, NR3C1, NR4A1, NR4A2, NR5A1, NR5A2, PGR, PPARA, PPARD, PPARG, RARA, RARB, RARG, ROR1, RORA, RORC, RXRA, RXRB, RXRG, THRA, THRB, VDR]	TRUE
WP:179	WikiPathways_09.11.2015	Cell Cycle	[-1]	[Group17, Group25, Group6]	4	3.883495	0.03208858675722838	1.0	{Group17=6.776241579089485E-11, Group25=0.0014192920911883721, Group6=0.0018572031677458632}	{Group17=4.607844273780849E-9, Group25=0.0766417729241721, Group6=0.09843176789053075}	[ABL1, ATM, MEN1, PRKDC]	[ABL1, APC, ARF1, ATM, ATR, BUB1, BUB1B, BUB3, CCNA1, CCNA2, CCNB1, CCNB2, CCNB3, CCND2, CCND3, CCNE1, CCNE2, CCNH, CDC14A, CDC14B, CDC20, CDC25A, CDC25B, CDC25C, CDC45, CDC6, CDC7, CDH1, CDK1, CDK2, CDK4, CDK6, CDKN1A, CDKN1B, CDKN2A, CHEK1, CHEK2, DBF4, E2F1, E2F2, E2F3, E2F4, E2F5, E2F6, EP300, ESPL1, GADD45A, GSK3B, HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, KITLG, MAD1L1, MAD2L1, MAD2L2, MCM10, MCM2, MCM3, MCM4, MCM5, MCM6, MCM7, MCM8, MCM9, MDM2, MEN1, MPEG1, ORC1, ORC2, ORC3, ORC4, ORC5, ORC6, PCNA, PKMYT1, PLK1, PRKDC, PTTG1, PTTG2, PTTG3P, RB1, RBL1, SKP2, SMAD3, SMAD4, SMC1A, TBC1D8, TFDP1, TGFB1, TP53, UBE2F, WEE1, YWHAB, YWHAE, YWHAG, YWHAH, YWHAQ, YWHAZ]	FALSE
WP:185	WikiPathways_09.11.2015	Integrin-mediated Cell Adhesion	[-1]	[Group1, Group12, Group15, Group27, Group32, Group34, Group48, Group53, Group64, Group67, Group68]	2	1.980198	0.333735328608664	1.0	{Group1=0.3422234010584369, Group12=0.2420215438602354, Group15=5.47972669334322E-4, Group27=0.003150245716997155, Group32=0.04886948215445072, Group34=0.023242299876161884, Group48=0.10903713332925667, Group53=6.567096321826248E-4, Group64=1.3778632235359839E-5, Group67=0.11782420498332685, Group68=3.328030031465086E-4}	{Group1=1.0, Group12=1.0, Group15=0.03068646948272203, Group27=0.15751228584985774, Group32=1.0, Group34=0.9296919950464754, Group48=1.0, Group53=0.036119029770044365, Group64=8.680538308276698E-4, Group67=1.0, Group68=0.01963537718564401}	[HRAS, PTK2]	[AKT1, AKT2, AKT3, ARAF, ARHGEF7, BCAR1, BRAF, CAPN1, CAPN10, CAPN11, CAPN2, CAPN3, CAPN5, CAPN6, CAPN7, CAPN9, CAPNS1, CAV1, CAV2, CAV3, CDC42, CRK, CSK, DOCK1, FYN, GIT2, GRB2, HRAS, ILK, ITGA1, ITGA10, ITGA11, ITGA2, ITGA2B, ITGA3, ITGA4, ITGA5, ITGA6, ITGA7, ITGA8, ITGA9, ITGAD, ITGAE, ITGAL, ITGAM, ITGAV, ITGAX, ITGB1, ITGB2, ITGB3, ITGB4, ITGB5, ITGB6, ITGB7, ITGB8, LOC100505984, MAP2K1, MAP2K2, MAP2K3, MAP2K5, MAP2K6, MAPK1, MAPK10, MAPK12, MAPK4, MAPK6, MAPK7, MYLK2, MYPN, PAK1, PAK2, PAK3, PAK4, PAK6, PDPK1, PIK3R2, PTK2, PXN, RAC1, RAC2, RAC3, RAF1, RAP1A, RAP1B, RAPGEF1, RHO, ROCK1, ROCK2, SEPP1, SHC1, SHC3, SORBS1, SOS1, SRC, TLN1, TNS1, VASP, VAV2, VAV3, VCL, ZYX]	TRUE
WP:186	WikiPathways_09.11.2015	Homologous recombination	[-1]	[Group51, Group61]	5	38.46154	2.247272054740486E-7	2.44952653966713E-5	{Group51=5.751852119082846E-12, Group61=3.758262700808551E-9}	{Group51=4.083815004548821E-10, Group61=2.518036009541729E-7}	[ATM, BRCA2, POLD1, RAD50, RAD51]	[ATM, BRCA2, MRE11A, NBN, POLD1, POLD2, POLD3, POLD4, RAD50, RAD51, RAD52, RAD54B, RPA1]	TRUE
WP:206	WikiPathways_09.11.2015	Fatty Acid Omega Oxidation	[-1]	[Group24]	1	6.25	0.17258577446938866	1.0	{Group24=0.7890042018472335}	{Group24=1.0}	[CYP2D6]	[ADH1A, ADH1B, ADH1C, ADH4, ADH6, ADH7, ALDH1A1, ALDH2, CYP1A1, CYP1A2, CYP2A6, CYP2D6, CYP2E1, CYP3A4, CYP4A11, CYP4A22]	FALSE
WP:229	WikiPathways_09.11.2015	Irinotecan Pathway	[-1]	[Group39]	1	7.142857	0.15272853922144577	1.0	{Group39=0.15272853922144577}	{Group39=1.0}	[ABCG2]	[ABCC1, ABCC2, ABCG2, APC, BCHE, CES1, CES2, CYP3A4, CYP3A5, NPC1, SLCO1B1, UGT1A1, UGT1A10, UGT1A9]	TRUE
WP:231	WikiPathways_09.11.2015	TNF alpha Signaling Pathway	[-1]	[Group18, Group20, Group37, Group53, Group57, Group68, Group74]	4	4.347826	0.022288569017630936	1.0	{Group18=2.2676648782666833E-5, Group20=4.853337156445499E-4, Group37=7.113870981722735E-7, Group53=6.567096321826248E-4, Group57=2.7626465873397032E-5, Group68=3.328030031465086E-4, Group74=0.5483333906310934}	{Group18=0.0014059522245253437, Group20=0.028149355507383896, Group37=4.624016138119778E-5, Group53=0.036119029770044365, Group57=0.001685214418277219, Group68=0.01963537718564401, Group74=1.0}	[BID, HRAS, KRAS, NRAS]	[AKT1, APAF1, BAD, BAX, BCL2L1, BID, BIRC2, BIRC3, BTRC, CASP3, CASP7, CASP8, CASP9, CCL2, CDC37, CFLAR, CHUK, CREBBP, CSNK2A1, CUL1, CYBA, DIABLO, FADD, FBXW11, GLUL, GRB2, HRAS, HSP90AA1, IKBKB, IKBKG, IL6, JUN, KRAS, KSR1, KSR2, MADD, MAP2K3, MAP2K4, MAP2K6, MAP2K7, MAP3K1, MAP3K14, MAP3K3, MAP3K5, MAP3K7, MAP3K8, MAP4K2, MAPK1, MAPK3, MAPK8, MAPK9, NFKB1, NFKB2, NFKBIA, NFKBIB, NFKBIE, NOX1, NOXO1, NRAS, NSMAF, OTUD7B, PLK1, PPP2CA, PRKCZ, PSMD2, PTPRCAP, PYGL, RAC1, RAF1, REL, RFFL, RFK, RIPK1, RIPK3, SELE, SKP1, SMPD2, SOS1, TAB1, TAB2, TAB3, TANK, TBK1, TNF, TNFAIP3, TNFRSF1A, TNFRSF1B, TRADD, TRAF1, TRAF2, TRAP1, TXN]	TRUE
WP:236	WikiPathways_09.11.2015	Adipogenesis	[-1]	[Group21, Group41, Group43, Group46, Group58, Group73]	3	2.3076923	0.1957582664468958	1.0	{Group21=0.060782830193602554, Group41=0.11610019037275422, Group43=0.27638591509599, Group46=0.013359738966869447, Group58=0.04294071628232707, Group73=0.09588739026439713}	{Group21=1.0, Group41=1.0, Group43=1.0, Group46=0.5744687755753862, Group58=1.0, Group73=1.0}	[CREB1, IL6ST, PPARA]	[ADIPOQ, AGPAT2, AGT, AHR, ASIP, BMP1, BMP2, BMP3, BMP4, BSCL2, CDKN1A, CEBPA, CEBPB, CEBPD, CELF1, CFD, CISD1, CNTFR, CREB1, CTNNB1, CYP26A1, CYP26B1, DDIT3, DLK1, DVL1, E2F1, E2F4, EBF1, EGR2, EPAS1, FAS, FOXC2, FOXO1, FRZB, FZD1, GADD45A, GADD45B, GATA2, GATA3, GATA4, GDF10, GH1, GTF3A, HIF1A, HMGA1, HNF1A, ID3, IGF1, IL6, IL6ST, INS, IRS1, IRS2, IRS4, KLF15, KLF5, KLF6, KLF7, LEP, LIF, LIFR, LIPE, LMNA, LPIN1, LPIN2, LPIN3, LPL, MBNL1, MEF2A, MEF2BNB-MEF2B, MEF2C, MEF2D, MIF, MIXL1, NAMPT, NCOA1, NCOA2, NCOR1, NCOR2, NDN, NR1H3, NR2F1, NR3C1, NRIP1, OSM, PCK1, PCK2, PLIN1, PLIN2, PNPLA3, PPARA, PPARD, PPARG, PPARGC1A, PRLR, PTGIS, RARA, RB1, RBL1, RBL2, RETN, RORA, RXRA, RXRG, SCD, SERPINE1, SFRP4, SLC2A4, SMAD3, SOCS1, SOCS3, SP1, SPOCK1, SREBF1, STAT1, STAT2, STAT3, STAT5A, STAT5B, STAT6, TGFB1, TNF, TRIB3, TWIST1, UCP1, WNT1, WNT10B, WNT5B, WWTR1, ZMPSTE24]	TRUE
WP:244	WikiPathways_09.11.2015	Alpha 6 Beta 4 signaling pathway	[-1]	[Group10, Group12, Group14, Group15, Group27, Group32, Group33, Group34, Group4, Group46, Group47, Group48, Group53, Group57, Group64, Group67, Group72]	3	9.090909	0.006541466871618951	0.5167758828578971	{Group10=0.015320357032764444, Group12=0.2420215438602354, Group14=0.003307743828384746, Group15=5.47972669334322E-4, Group27=0.003150245716997155, Group32=0.04886948215445072, Group33=0.013749297939086429, Group34=0.023242299876161884, Group4=2.3359082094591414E-6, Group46=0.013359738966869447, Group47=0.005968472152834779, Group48=0.10903713332925667, Group53=6.567096321826248E-4, Group57=2.7626465873397032E-5, Group64=1.3778632235359839E-5, Group67=0.11782420498332685, Group72=0.004865643191837814}	{Group10=0.6281346383433422, Group12=1.0, Group14=0.1587717037624678, Group15=0.03068646948272203, Group27=0.15751228584985774, Group32=1.0, Group33=0.57747051344163, Group34=0.9296919950464754, Group4=1.4949812540538505E-4, Group46=0.5744687755753862, Group47=0.26858124687756507, Group48=1.0, Group53=0.036119029770044365, Group57=0.001685214418277219, Group64=8.680538308276698E-4, Group67=1.0, Group72=0.22381958682453945}	[HRAS, MTOR, PTK2]	[AKT1, EIF4EBP1, GAB1, GRB2, HRAS, IRS1, IRS2, ITGA6, ITGB4, LAMA1, LAMA2, LAMA3, LAMA5, LAMB1, LAMB2, LAMB3, LAMC1, LAMC2, MAPK1, MAPK14, MAPK3, MTOR, PIK3R1, PIK3R2, PRKCA, PRKCD, PTK2, PTPN11, RAC1, RHOA, SHC1, SOS1, SRC]	TRUE
WP:254	WikiPathways_09.11.2015	Apoptosis	[-1]	[Group75]	3	3.5714285	0.07524741664179305	1.0	{Group75=0.12156046396649858}	{Group75=1.0}	[BID, SCAF11, TNFRSF10B]	[AKT1, APAF1, BAD, BAK1, BAX, BBC3, BCL2, BCL2L1, BCL2L11, BCL2L2, BID, BIRC2, BIRC3, BIRC5, BNIP3L, BOK, CASP1, CASP10, CASP2, CASP3, CASP4, CASP6, CASP7, CASP8, CASP9, CDKN2A, CFLAR, CHUK, CRADD, CYCS, DFFA, DFFB, DIABLO, FADD, FAS, FASLG, GZMB, HELLS, HRK, IGF1, IGF1R, IGF2, IKBKB, IKBKG, IRF1, IRF2, IRF3, IRF4, IRF5, IRF6, IRF7, JUN, LTA, MAP2K4, MAP3K1, MAPK10, MCL1, MDM2, MYC, NFKB1, NFKBIA, NFKBIB, NFKBIE, PIK3R1, PMAIP1, PRF1, RELA, RIPK1, SCAF11, TNF, TNFRSF10B, TNFRSF1A, TNFRSF1B, TNFRSF21, TNFRSF25, TNFSF10, TP53, TP63, TP73, TRADD, TRAF1, TRAF2, TRAF3, XIAP]	FALSE
WP:286	WikiPathways_09.11.2015	IL-3 Signaling Pathway	[-1]	[Group1, Group12, Group20, Group27, Group41, Group48]	1	2.0408163	0.4413265394440571	1.0	{Group1=0.3422234010584369, Group12=0.2420215438602354, Group20=4.853337156445499E-4, Group27=0.003150245716997155, Group41=0.11610019037275422, Group48=0.10903713332925667}	{Group1=1.0, Group12=1.0, Group20=0.028149355507383896, Group27=0.15751228584985774, Group41=1.0, Group48=1.0}	[HRAS]	[AKT1, BAD, BCL2, BCL2L1, CBL, CCR3, CD69, CD86, CRKL, CSF2RB, CXCL8, ENPP3, FOS, FYN, GAB2, GRB2, HCK, HRAS, IL3, IL3RA, IL5RA, INPP5D, JAK1, JAK2, JUN, LYN, MAP2K1, MAPK1, MAPK3, MAPK8, PIK3CD, PIK3R1, PIK3R2, PRKACA, PTPN11, PTPN6, RAF1, RAPGEF1, SHC1, SOS1, SRC, STAT3, STAT5A, STAT5B, SYK, TGFB1, VAV1, YWHAB, YWHAQ]	FALSE
WP:289	WikiPathways_09.11.2015	Myometrial Relaxation and Contraction Pathways	[-1]	[Group1, Group13, Group19, Group21, Group35, Group42, Group59, Group76]	2	1.2820513	0.7058573275455989	1.0	{Group1=0.3422234010584369, Group13=0.33292187912560667, Group19=1.0, Group21=0.060782830193602554, Group35=0.3257975894079523, Group42=0.09746363511951099, Group59=0.15417153306498815, Group76=0.4084685652197573}	{Group1=1.0, Group13=1.0, Group19=1.0, Group21=1.0, Group35=1.0, Group42=1.0, Group59=1.0, Group76=1.0}	[CREB1, GRK6]	[ACKR3, ACTA1, ACTA2, ACTB, ACTC1, ACTG1, ADCY1, ADCY2, ADCY3, ADCY4, ADCY5, ADCY6, ADCY7, ADCY8, ADCY9, ADM, ARRB1, ARRB2, ATF1, ATF2, ATF3, ATF4, ATF5, ATF6B, ATP2A2, ATP2A3, CACNB3, CALCA, CALD1, CALM1, CALM2, CALM3, CAMK2A, CAMK2B, CAMK2D, CAMK2G, CNN1, CNN2, CORIN, CRCP, CREB1, CREB3, CRH, CRHR1, DGKZ, ETS2, FLJ10038, FOS, GABPA, GABPB1, GJA1, GNAQ, GNAS, GNB1, GNB2, GNB3, GNB4, GNB5, GNG11, GNG12, GNG13, GNG2, GNG3, GNG4, GNG5, GNG7, GNG8, GNGT1, GPR182, GRK4, GRK5, GRK6, GSTO1, GUCA2A, GUCA2B, GUCY1A3, IGFBP1, IGFBP2, IGFBP3, IGFBP4, IGFBP5, IGFBP6, IL1B, IL6, ITPR1, ITPR2, ITPR3, JUN, LPAR1, MAFF, MYL2, MYL4, MYLK2, NFKB1, NOS1, NOS3, OXT, OXTR, PDE4B, PDE4D, PKIA, PKIB, PKIG, PLCB3, PLCD1, PLCG1, PLCG2, PRKACA, PRKACB, PRKAR1A, PRKAR1B, PRKAR2A, PRKAR2B, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PRKCH, PRKCQ, PRKCZ, PRKD1, RAMP1, RAMP2, RAMP3, RGS1, RGS10, RGS11, RGS14, RGS16, RGS17, RGS18, RGS19, RGS2, RGS20, RGS3, RGS4, RGS5, RGS6, RGS7, RGS9, RLN1, RXFP1, RXFP2, RYR1, RYR2, RYR3, SFN, SLC8A1, SP1, YWHAB, YWHAE, YWHAG, YWHAH, YWHAQ, YWHAZ]	TRUE
WP:299	WikiPathways_09.11.2015	Nuclear Receptors in Lipid Metabolism and Toxicity	[-1]	[Group24, Group38, Group58, Group63]	2	5.5555553	0.06628716678722593	1.0	{Group24=0.7890042018472335, Group38=0.8126859102118735, Group58=0.04294071628232707, Group63=0.296656766532177}	{Group24=1.0, Group38=1.0, Group58=1.0, Group63=1.0}	[ABCB1, PPARA]	[ABCA1, ABCB1, ABCB11, ABCB4, ABCC2, ABCC3, ABCD2, ABCD3, ABCG1, ABCG5, CYP1A2, CYP24A1, CYP26A1, CYP27B1, CYP2B6, CYP2C9, CYP2E1, CYP3A4, CYP4A11, CYP4A22, CYP4B1, CYP7A1, CYP8B1, MIR33A, MIR33B, NR1H3, NR1H4, NR1I2, NR1I3, PPARA, PPARD, PPARG, RARA, RARB, RARG, VDR]	FALSE
WP:304	WikiPathways_09.11.2015	Kit receptor signaling pathway	[-1]	[Group1, Group12, Group20, Group27, Group41, Group48]	1	1.6949153	0.5042772958558512	1.0	{Group1=0.3422234010584369, Group12=0.2420215438602354, Group20=4.853337156445499E-4, Group27=0.003150245716997155, Group41=0.11610019037275422, Group48=0.10903713332925667}	{Group1=1.0, Group12=1.0, Group20=0.028149355507383896, Group27=0.15751228584985774, Group41=1.0, Group48=1.0}	[HRAS]	[AKT1, BAD, BCL2, BTK, CBL, CRK, CRKL, DOK1, EP300, FOS, FOXO3, FYN, GAB2, GRB10, GRB2, GRB7, HRAS, INPP5D, JAK2, JUNB, KIT, KITLG, LYN, MAP2K1, MAP2K2, MAPK1, MAPK14, MAPK3, MAPK8, MAPT, MATK, MITF, PIK3R1, PIK3R2, PLCG1, PRKCA, PRKCB, PTPN11, PTPN6, RAF1, RPS6, RPS6KA1, RPS6KA3, RPS6KB1, SH2B2, SHC1, SNAI1, SNAI2, SOCS1, SOCS6, SOS1, SRC, STAT1, STAT3, STAT5A, STAT5B, TBX2, TEC, VAV1]	FALSE
WP:306	WikiPathways_09.11.2015	Focal Adhesion	[-1]	[Group10, Group27, Group48, Group64, Group66, Group68, Group70]	5	2.617801	0.07228844309470846	1.0	{Group10=0.015320357032764444, Group27=0.003150245716997155, Group48=0.10903713332925667, Group64=1.3778632235359839E-5, Group66=0.09528179928216532, Group68=3.328030031465086E-4, Group70=0.37553683169036156}	{Group10=0.6281346383433422, Group27=0.15751228584985774, Group48=1.0, Group64=8.680538308276698E-4, Group66=1.0, Group68=0.01963537718564401, Group70=1.0}	[FLT1, HRAS, PIK3CA, PTEN, PTK2]	[ACTB, ACTG1, ACTN1, AKT1, AKT2, AKT3, ARAF, ARHGAP5, BAD, BCAR1, BCL2, BIRC2, BIRC3, BLK, BRAF, CAPN1, CAV1, CAV2, CAV3, CCND1, CCND2, CCND3, CDC42, CHAD, COL11A1, COL11A2, COL1A1, COL1A2, COL2A1, COL3A1, COL4A1, COL4A2, COL4A4, COL4A6, COL5A1, COL5A2, COL5A3, COL6A2, COMP, CRK, CTNNB1, DIAPH1, DOCK1, EGF, EGFR, ELK1, ERBB2, FARP2, FGR, FIGF, FLNA, FLT1, FN1, FYN, GRB2, GSK3B, HCK, HGF, HRAS, IBSP, IGF1, IGF1R, ILK, ITGA10, ITGA11, ITGA2, ITGA2B, ITGA3, ITGA4, ITGA5, ITGA6, ITGA7, ITGA8, ITGA9, ITGAD, ITGAE, ITGAL, ITGAM, ITGAV, ITGAX, ITGB1, ITGB2, ITGB3, ITGB4, ITGB5, ITGB6, ITGB7, ITGB8, JUN, KDR, LAMA1, LAMA2, LAMA3, LAMA4, LAMA5, LAMB1, LAMB2, LAMB3, LAMC1, LAMC2, LAMC3, LOC100505984, MAP2K1, MAP2K2, MAP2K3, MAP2K5, MAP2K6, MAPK1, MAPK12, MAPK4, MAPK6, MAPK7, MAPK8, MAPK9, MET, MYL6, MYLK, MYLK2, PAK1, PAK2, PAK3, PAK4, PAK6, PAK7, PARVB, PDGFA, PDGFB, PDGFC, PDGFD, PDGFRA, PDGFRB, PDPK1, PELO, PGF, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PIK3R4, PIK3R5, PIP5K1C, PPP1R12A, PTEN, PTK2, PTK6, PXN, RAC1, RAC2, RAC3, RAF1, RAP1A, RAP1B, RAPGEF1, RELN, RHOA, RHOB, ROCK1, ROCK2, SEPP1, SHC1, SHC3, SOS1, SPP1, SRC, SRMS, STYK1, TESK2, THBS1, THBS2, THBS3, THBS4, TLN1, TNC, TNK1, TNK2, TNN, TNR, TNXB, TXK, VASP, VAV1, VCL, VEGFA, VEGFB, VEGFC, VTN, VWF, XIAP, ZYX]	FALSE
WP:313	WikiPathways_09.11.2015	Signaling of Hepatocyte Growth Factor Receptor	[-1]	[Group10, Group18, Group26, Group27, Group33, Group37, Group4, Group48, Group53, Group64, Group66, Group68, Group70]	4	11.764706	6.116853900331306E-4	0.05749842666311428	{Group10=0.015320357032764444, Group18=2.2676648782666833E-5, Group26=1.6750572661729398E-4, Group27=0.003150245716997155, Group33=0.013749297939086429, Group37=7.113870981722735E-7, Group4=2.3359082094591414E-6, Group48=0.10903713332925667, Group53=6.567096321826248E-4, Group64=1.3778632235359839E-5, Group66=0.09528179928216532, Group68=3.328030031465086E-4, Group70=0.37553683169036156}	{Group10=0.6281346383433422, Group18=0.0014059522245253437, Group26=0.010050343597037638, Group27=0.15751228584985774, Group33=0.57747051344163, Group37=4.624016138119778E-5, Group4=1.4949812540538505E-4, Group48=1.0, Group53=0.036119029770044365, Group64=8.680538308276698E-4, Group66=1.0, Group68=0.01963537718564401, Group70=1.0}	[HRAS, PIK3CA, PTEN, PTK2]	[CRK, CRKL, DOCK1, ELK1, FOS, GAB1, GRB2, HGF, HRAS, ITGA1, ITGB1, JUN, MAP2K1, MAP2K2, MAP4K1, MAPK1, MAPK3, MAPK8, MET, PAK1, PIK3CA, PTEN, PTK2, PTK2B, PTPN11, PXN, RAF1, RAP1A, RAP1B, RAPGEF1, RASA1, SOS1, SRC, STAT3]	TRUE
WP:314	WikiPathways_09.11.2015	FAS pathway and Stress induction of HSP regulation	[-1]	[Group65]	2	4.7619047	0.08667909303650473	1.0	{Group65=0.08667909303650473}	{Group65=1.0}	[PARP1, PRKDC]	[ACTA1, ACTB, ACTG1, APAF1, ARHGDIB, BCL2, CASP10, CASP3, CASP6, CASP7, CASP8, CASP9, CFLAR, CYCS, DAXX, DFFA, DFFB, FADD, FAF1, FAS, FASLG, HSPB1, IL1A, JUN, LMNA, LMNB1, LMNB2, MAP2K4, MAP3K1, MAP3K7, MAPK8, MAPKAPK2, MAPKAPK3, NFX1, PAK1, PAK2, PARP1, PRKDC, RB1, RIPK2, SPTAN1, TNF]	TRUE
WP:363	WikiPathways_09.11.2015	Wnt Signaling Pathway Netpath	[-1]	[Group13, Group31, Group32, Group35, Group36, Group48, Group52, Group54, Group72]	1	1.9230769	0.4609938725171702	1.0	{Group13=0.33292187912560667, Group31=0.18555280111792985, Group32=0.04886948215445072, Group35=0.3257975894079523, Group36=0.4341567002016995, Group48=0.10903713332925667, Group52=0.12732028864491843, Group54=0.2887596066788072, Group72=0.004865643191837814}	{Group13=1.0, Group31=1.0, Group32=1.0, Group35=1.0, Group36=1.0, Group48=1.0, Group52=1.0, Group54=1.0, Group72=0.22381958682453945}	[MTOR]	[AKT1, APC, ARRB2, AXIN1, AXIN2, BCL9, CCND1, CDK6, CSNK1A1, CSNK1D, CSNK1E, CSNK1G1, CTBP1, CTNNB1, DVL1, DVL2, DVL3, FRAT1, GCKR, GJA1, GSK3A, GSK3B, LEF1, LOC400927-CSNK1E, LRP5, LRP6, MAP3K7, MAPK1, MAPK8, MAPK9, MTOR, MYC, NFATC2, NLK, PI4K2A, PIP5K1B, PPARG, PRKCA, PRKCB, PRKCG, RAC1, RHOA, ROR1, ROR2, RYK, SOX1, TCF3, TCF4, TCF7L2, TEK, TSC1, TSC2]	FALSE
WP:364	WikiPathways_09.11.2015	IL-6 signaling pathway	[-1]	[Group41, Group43, Group56, Group73]	1	2.3255813	0.3998533436855761	1.0	{Group41=0.11610019037275422, Group43=0.27638591509599, Group56=0.3398859873930151, Group73=0.09588739026439713}	{Group41=1.0, Group43=1.0, Group56=1.0, Group73=1.0}	[IL6ST]	[AGT, AKT1, BAD, BCL2L1, CREBBP, CRP, GAB1, GRB2, GSK3B, HCK, HDAC1, IL6, IL6R, IL6ST, IRF1, JAK1, JAK2, JUNB, MAP2K1, MAP2K2, MAP2K4, MAP3K7, MAPK1, MAPK3, NCOA1, NLK, NR2F6, PIK3R1, PIK3R2, PRDM1, PRKCD, PTPN11, RAC1, RPS6KB1, SHC1, SOCS3, SOS1, STAT1, STAT3, TIMP1, TYK2, VAV1, VIP]	FALSE
WP:366	WikiPathways_09.11.2015	TGF beta Signaling Pathway	[-1]	[Group27, Group32, Group67]	2	1.5151515	0.6682815836017715	1.0	{Group27=0.003150245716997155, Group32=0.04886948215445072, Group67=0.11782420498332685}	{Group27=0.15751228584985774, Group32=1.0, Group67=1.0}	[PTK2, STRAP]	[AKT1, APP, ATF2, ATF3, AXIN1, BCAR1, BTRC, CAV1, CCNB2, CCND1, CDC42, CDK1, CDKN1A, CDKN2B, CITED1, COL1A2, COPS5, CREBBP, CUL1, DAB2, DCP1A, E2F4, E2F5, EID2, EP300, ETS1, FN1, FOS, FOSB, FOXH1, FOXP3, GRB2, HDAC1, HGS, ITCH, ITGA2, ITGB1, ITGB3, ITGB4, JUN, JUNB, JUND, KLF10, KLF11, KLF6, LIMK2, MAP2K1, MAP2K2, MAP2K3, MAP2K4, MAP2K6, MAP3K7, MAP4K1, MAPK1, MAPK14, MAPK4, MAPK8, MAPK9, MEF2A, MEF2C, MET, MMP1, MMP12, MYC, NEDD4L, NEDD9, NUP153, NUP214, PAK2, PARD6A, PDK1, PIAS1, PIAS2, PIK3R1, PIK3R2, PJA1, PML, PPM1A, PRKAR2A, PTK2, RAC1, RAF1, RBL1, RBL2, RBX1, RHOA, RNF111, ROCK1, RUNX2, SHC1, SIK1, SIN3A, SKI, SKIL, SKP1, SMAD2, SMAD3, SMAD4, SMAD7, SMURF1, SMURF2, SNIP1, SNW1, SOS1, SP1, SPTBN1, SRC, STAMBPL1, STRAP, SUMO1, TAB1, TERT, TFDP1, TGFB1, TGFB1I1, TGFBR1, TGFBR2, TGFBR3, TGIF1, THBS1, TNC, TP53, TRAF6, TRAP1, UBE2I, UCHL5, WWP1, YAP1, ZEB1, ZEB2, ZFYVE16, ZFYVE9]	FALSE
WP:382	WikiPathways_09.11.2015	MAPK Signaling Pathway	[-1]	[Group11, Group20, Group53, Group57, Group71, Group74]	3	1.7857143	0.4486285226487127	1.0	{Group11=0.0020227372439293166, Group20=4.853337156445499E-4, Group53=6.567096321826248E-4, Group57=2.7626465873397032E-5, Group71=0.257855130160565, Group74=0.5483333906310934}	{Group11=0.10518233668432446, Group20=0.028149355507383896, Group53=0.036119029770044365, Group57=0.001685214418277219, Group71=1.0, Group74=1.0}	[KRAS, NRAS, PPP3CA]	[ACVR1B, ACVR1C, AKT1, AKT2, AKT3, ARRB1, ARRB2, ATF2, ATF4, BDNF, BRAF, CASP1, CASP2, CASP3, CASP6, CASP7, CASP8, CASP9, CD14, CDC25B, CDC42, CRK, CRKL, DAXX, DDIT3, DUSP1, DUSP10, DUSP4, DUSP5, DUSP6, DUSP7, ECSIT, EGF, EGFR, ELK1, FAS, FASLG, FGF4, FGFR1, FLNA, FOS, GADD45A, GCK, GNA12, GRB2, HSPA1A, HSPA5, HSPA8, HSPB1, HSPB2, IKBKB, IKBKG, IL1A, IL1B, IL1R1, IL1R2, JUN, JUND, KRAS, LAMTOR3, LRRK2, MAP2K1, MAP2K2, MAP2K3, MAP2K4, MAP2K5, MAP2K6, MAP2K7, MAP3K1, MAP3K11, MAP3K12, MAP3K13, MAP3K14, MAP3K2, MAP3K4, MAP3K5, MAP3K6, MAP3K7, MAP3K8, MAP4K1, MAP4K3, MAP4K4, MAPK1, MAPK10, MAPK12, MAPK13, MAPK14, MAPK3, MAPK4, MAPK6, MAPK7, MAPK8, MAPK8IP3, MAPK9, MAPKAPK2, MAPKAPK5, MAPT, MAX, MEF2C, MINK1, MKNK1, MOS, MRAS, MYC, NF1, NFATC1, NFKB1, NGF, NLK, NR4A1, NRAS, NTF4, NTRK1, PAK1, PAK2, PDGFB, PDGFRB, PLA2G10, PLA2G5, PPM1A, PPM1B, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, PPP5C, PRKACA, PRKCB, PRKCD, PRKCG, PRKCH, PRKCZ, PTPN5, PTPN7, PTPRR, RAC1, RAC2, RAF1, RAP1A, RAP1B, RASA1, RASA2, RASGRF2, RASGRP1, RASGRP4, RPS6KA3, RPS6KA5, SH2D1A, SOS2, SRF, STK3, STMN1, TAB1, TAB2, TAOK1, TAOK2, TGFB1, TGFB2, TGFB3, TGFBR1, TGFBR2, TMEM37, TNF, TP53, TRAF2, TRAF6, ZAK]	FALSE
WP:384	WikiPathways_09.11.2015	Apoptosis Modulation by HSP70	[-1]	[Group25, Group50, Group75]	1	5.263158	0.20151722510892747	1.0	{Group25=0.0014192920911883721, Group50=0.3398859873930151, Group75=0.12156046396649858}	{Group25=0.0766417729241721, Group50=1.0, Group75=1.0}	[BID]	[AIFM1, APAF1, BID, CASP2, CASP3, CASP6, CASP7, CASP8, CASP9, CYCS, FADD, FAS, FASLG, HSPA1A, MAP3K1, MAPK10, NFKB1, RIPK1, TNFRSF1A]	FALSE
WP:391	WikiPathways_09.11.2015	Mitochondrial Gene Expression	[-1]	[Group1, Group13, Group19, Group21, Group50, Group54, Group56, Group59, Group71, Group76]	2	10.0	0.02251560118105851	1.0	{Group1=0.3422234010584369, Group13=0.33292187912560667, Group19=1.0, Group21=0.060782830193602554, Group50=0.3398859873930151, Group54=0.2887596066788072, Group56=0.3398859873930151, Group59=0.15417153306498815, Group71=0.257855130160565, Group76=0.4084685652197573}	{Group1=1.0, Group13=1.0, Group19=1.0, Group21=1.0, Group50=1.0, Group54=1.0, Group56=1.0, Group59=1.0, Group71=1.0, Group76=1.0}	[CREB1, PPP3CA]	[CAMK4, CREB1, ESRRA, FLJ10038, GABPA, GABPB1, HCFC1, MTERF1, MTERF3, MYEF2, NRF1, POLRMT, PPARGC1A, PPARGC1B, PPP3CA, PPRC1, SP1, TFAM, TFB1M, TFB2M]	FALSE
WP:395	WikiPathways_09.11.2015	IL-4 Signaling Pathway	[-1]	[Group19, Group22, Group36, Group66, Group70]	1	1.8518518	0.47372585152465857	1.0	{Group19=1.0, Group22=0.11196305953800512, Group36=0.4341567002016995, Group66=0.09528179928216532, Group70=0.37553683169036156}	{Group19=1.0, Group22=1.0, Group36=1.0, Group66=1.0, Group70=1.0}	[PIK3CA]	[AKT1, ATF2, BAD, BIRC5, CBL, CEBPA, CEBPB, CHUK, DOK2, ELK1, EP300, FES, FLNA, FOS, GAB2, GATA3, GRB2, HRH1, IKBKB, IL2RG, IL4, IL4R, INPP5D, IRS1, IRS2, JAK1, JAK2, JAK3, MAPK1, MAPK11, MAPK14, MAPK3, NFIL3, NFKB1, NFKBIA, PIK3CA, PIK3CD, PIK3R1, PIK3R2, PTPN11, PTPN6, RELA, RPS6KB1, SHC1, SOCS1, SOCS3, SOCS5, SOS1, STAT1, STAT3, STAT5A, STAT5B, STAT6, TYK2]	FALSE
WP:400	WikiPathways_09.11.2015	p38 MAPK Signaling Pathway	[-1]	[Group1, Group12, Group13, Group19, Group21, Group27, Group33, Group34, Group41, Group46, Group47, Group59, Group76]	2	5.882353	0.05990558759334167	1.0	{Group1=0.3422234010584369, Group12=0.2420215438602354, Group13=0.33292187912560667, Group19=1.0, Group21=0.060782830193602554, Group27=0.003150245716997155, Group33=0.013749297939086429, Group34=0.023242299876161884, Group41=0.11610019037275422, Group46=0.013359738966869447, Group47=0.005968472152834779, Group59=0.15417153306498815, Group76=0.4084685652197573}	{Group1=1.0, Group12=1.0, Group13=1.0, Group19=1.0, Group21=1.0, Group27=0.15751228584985774, Group33=0.57747051344163, Group34=0.9296919950464754, Group41=1.0, Group46=0.5744687755753862, Group47=0.26858124687756507, Group59=1.0, Group76=1.0}	[CREB1, HRAS]	[ATF2, CDC42, CREB1, DAXX, DDIT3, ELK1, GRB2, HMGN1, HRAS, HSPB1, MAP2K4, MAP2K6, MAP3K1, MAP3K5, MAP3K7, MAP3K9, MAPK14, MAPKAPK2, MAPKAPK5, MAX, MEF2D, MKNK1, MYC, PLA2G4A, RAC1, RASGRF1, RIPK1, RPS6KA5, SHC1, STAT1, TGFB2, TGFBR1, TRADD, TRAF2]	FALSE
WP:404	WikiPathways_09.11.2015	Nucleotide Metabolism	[-1]	[Group7]	2	10.526316	0.02041631512027884	1.0	{Group7=0.031462437430308424}	{Group7=1.0}	[POLD1, RRM1]	[ADSL, ADSS, DHFR, HPRT1, IMPDH1, MTHFD2, NME2, OAZ1, POLA1, POLB, POLD1, POLG, PRPS1, PRPS2, RRM1, RRM2, RRM2B, SAT1, SRM]	TRUE
WP:405	WikiPathways_09.11.2015	Eukaryotic Transcription Initiation	[-1]	[Group2]	2	4.5454545	0.09384971260086374	1.0	{Group2=1.0}	{Group2=1.0}	[POLR1B, POLR2A]	[AK6, CCNH, CDK7, ERCC2, ERCC3, GTF2A2, GTF2B, GTF2E1, GTF2E2, GTF2F2, GTF2H1, GTF2H2, GTF2H2C, GTF2H3, GTF2H4, ILK, LOC101060521, MNAT1, POLR1A, POLR1B, POLR1D, POLR1E, POLR2A, POLR2B, POLR2C, POLR2E, POLR2F, POLR2G, POLR2H, POLR2I, POLR2J, POLR2K, POLR3B, POLR3D, POLR3E, POLR3H, POLR3K, TAF12, TAF13, TAF5, TAF6, TAF7, TAF9, TBP]	TRUE
WP:411	WikiPathways_09.11.2015	mRNA Processing	[-1]	[Group2]	1	0.78740156	1.0	1.0	{Group2=1.0}	{Group2=1.0}	[POLR2A]	[CD2BP2, CDC40, CELF1, CELF2, CELF4, CLASRP, CLK1, CLK2, CLK3, CLK4, CLP1, CPSF1, CPSF2, CPSF3, CPSF4, CSTF1, CSTF2, CSTF2T, CSTF3, DDX1, DDX20, DHX15, DHX16, DHX38, DHX8, DHX9, DICER1, DNAJC8, EFTUD2, FUS, HNRNPA1, HNRNPA2B1, HNRNPAB, HNRNPC, HNRNPD, HNRNPH1, HNRNPH2, HNRNPK, HNRNPL, HNRNPM, HNRNPR, HNRNPU, LSM2, LSM7, METTL3, NCBP1, NCBP2, NONO, NUDT21, NXF1, PABPN1, PAPOLA, PCBP2, PHF5A, POLR2A, PPM1G, PRMT1, PRMT2, PRPF18, PRPF3, PRPF4, PRPF40A, PRPF4B, PRPF6, PRPF8, PSKH1, PTBP1, PTBP2, RBM17, RBM39, RBM5, RBMX, RNGTT, RNMT, RNPS1, RNU2-1, SF3A1, SF3A2, SF3A3, SF3B1, SF3B2, SF3B3, SF3B4, SF3B5, SFPQ, SFSWAP, SMC1A, SNRNP40, SNRNP70, SNRPA, SNRPA1, SNRPB, SNRPB2, SNRPD1, SNRPD2, SNRPD3, SNRPE, SNRPF, SNRPG, SNRPN, SNU13, SPOP, SREK1, SRP54, SRPK1, SRPK2, SRRM1, SRSF1, SRSF10, SRSF2, SRSF3, SRSF4, SRSF5, SRSF6, SRSF7, SRSF9, SUGP1, SUGP2, SUPT5H, TMED10, TRA2B, TXNL4A, U2AF1, U2AF1L5, U2AF2, XRN2, YBX1]	FALSE
WP:422	WikiPathways_09.11.2015	MAPK Cascade	[-1]	[Group11, Group12, Group15, Group18, Group20, Group37, Group46, Group53, Group57, Group68, Group74]	3	10.344828	0.004528745482593545	0.3622996386074836	{Group11=0.0020227372439293166, Group12=0.2420215438602354, Group15=5.47972669334322E-4, Group18=2.2676648782666833E-5, Group20=4.853337156445499E-4, Group37=7.113870981722735E-7, Group46=0.013359738966869447, Group53=6.567096321826248E-4, Group57=2.7626465873397032E-5, Group68=3.328030031465086E-4, Group74=0.5483333906310934}	{Group11=0.10518233668432446, Group12=1.0, Group15=0.03068646948272203, Group18=0.0014059522245253437, Group20=0.028149355507383896, Group37=4.624016138119778E-5, Group46=0.5744687755753862, Group53=0.036119029770044365, Group57=0.001685214418277219, Group68=0.01963537718564401, Group74=1.0}	[HRAS, KRAS, NRAS]	[ARAF, BRAF, ELK1, HRAS, JUN, KRAS, MAP2, MAP2K1, MAP2K2, MAP2K3, MAP2K4, MAP2K6, MAP2K7, MAP3K1, MAP3K12, MAP3K2, MAP3K3, MAPK1, MAPK10, MAPK12, MAPK14, MAPK3, MBP, NRAS, PLCB3, RAF1, RASA3, RRAS, SIPA1]	TRUE
WP:430	WikiPathways_09.11.2015	Statin Pathway	[-1]	[Group3]	1	3.2258065	0.3076285937979914	1.0	{Group3=0.3076285937979914}	{Group3=1.0}	[APOC1]	[ABCA1, ABCG5, ABCG8, ACSS1, APOA1, APOA2, APOA4, APOA5, APOB, APOC1, APOC2, APOC3, APOE, CETP, CYP7A1, DGAT1, FDFT1, HMGCR, LCAT, LDLR, LIPC, LPL, LRP1, MIR33A, MIR33B, MTTP, PDIA2, PLTP, SCARB1, SOAT1, SQLE]	TRUE
WP:437	WikiPathways_09.11.2015	EGF/EGFR Signaling Pathway	[-1]	[Group15, Group18, Group26, Group30, Group33, Group34, Group4, Group46, Group47, Group48, Group53, Group57, Group64]	8	4.9079757	5.563128931689762E-4	0.052849724851052736	{Group15=5.47972669334322E-4, Group18=2.2676648782666833E-5, Group26=1.6750572661729398E-4, Group30=2.972243278064436E-11, Group33=0.013749297939086429, Group34=0.023242299876161884, Group4=2.3359082094591414E-6, Group46=0.013359738966869447, Group47=0.005968472152834779, Group48=0.10903713332925667, Group53=6.567096321826248E-4, Group57=2.7626465873397032E-5, Group64=1.3778632235359839E-5}	{Group15=0.03068646948272203, Group18=0.0014059522245253437, Group26=0.010050343597037638, Group30=2.080570294645105E-9, Group33=0.57747051344163, Group34=0.9296919950464754, Group4=1.4949812540538505E-4, Group46=0.5744687755753862, Group47=0.26858124687756507, Group48=1.0, Group53=0.036119029770044365, Group57=0.001685214418277219, Group64=8.680538308276698E-4}	[ABL1, AURKA, CREB1, HRAS, KRAS, MTOR, PTEN, PTK2]	[ABI1, ABL1, AKT1, AP2A1, AP2B1, AP2M1, AP2S1, ARF6, ARHGEF1, ASAP1, ATF1, ATXN2, AURKA, BCAR1, BRAF, CAMK2A, CAV1, CAV2, CBL, CBLB, CBLC, CDC42, CFL1, COX2, CREB1, CRK, CRKL, CSK, DNM1, DOK2, E2F1, EGF, EGFR, EIF4EBP1, ELK1, ELK4, EPN1, EPS15, EPS15L1, EPS8, ERBB2, ERRFI1, FOS, FOSB, FOXO1, FOXO4, GAB1, GAB2, GJA1, GRB10, GRB2, HGS, HRAS, INPP5D, INPPL1, IQGAP1, IQSEC1, ITCH, JAK1, JAK2, JUN, JUND, KRAS, LIMK2, LOC100505585, MAP2K1, MAP2K2, MAP2K5, MAP3K1, MAP3K2, MAP3K3, MAP3K4, MAP4K1, MAPK1, MAPK14, MAPK4, MAPK7, MAPK8, MAPK9, MEF2A, MEF2C, MEF2D, MTOR, MYBL2, NCK1, NCK2, NCOA3, NDUFA13, NEDD4, NEDD8, NOS3, PAK1, PCNA, PDPK1, PEBP1, PIAS3, PIK3C2B, PIK3R1, PIK3R2, PLCE1, PLCG1, PLD1, PLD2, PLSCR1, PRKCA, PRKCB, PRKCD, PRKCI, PRKCZ, PTEN, PTK2, PTK2B, PTK6, PTPN11, PTPN12, PTPN5, PTPRR, PXDN, RAB5A, RAC1, RAF1, RALA, RALB, RALBP1, RALGDS, RAP1A, RASA1, REPS2, RICTOR, RIN1, ROCK1, RPS6KA1, RPS6KA2, RPS6KA3, RPS6KA5, RPS6KB1, SH2D2A, SH3GL2, SH3GL3, SH3KBP1, SHC1, SOS1, SOS2, SP1, SPRY2, SRC, STAM, STAM2, STAMBP, STAT1, STAT3, STAT5A, STAT5B, STMN1, STXBP1, SYNJ1, TNK2, TWIST1, USP6NL, USP8, VAV1, VAV2, VAV3]	TRUE
WP:438	WikiPathways_09.11.2015	Non-homologous end joining	[-1]	[Group5]	4	57.142857	5.848040361821712E-7	6.140442379912798E-5	{Group5=5.848040361821712E-7}	{Group5=3.8597066388023297E-5}	[PRKDC, RAD50, XRCC4, XRCC6]	[MRE11A, NHEJ1, PRKDC, RAD50, XRCC4, XRCC5, XRCC6]	TRUE
WP:466	WikiPathways_09.11.2015	DNA Replication	[-1]	[Group7]	2	4.7619047	0.08667909303650473	1.0	{Group7=0.031462437430308424}	{Group7=1.0}	[POLD1, POLE]	[CDC45, CDC6, CDC7, CDK2, CDT1, DBF4, GMNN, MCM10, MCM2, MCM3, MCM4, MCM5, MCM6, MCM7, ORC1, ORC2, ORC3, ORC4, ORC5, ORC6, PCNA, POLA1, POLA2, POLD1, POLD2, POLD3, POLD4, POLE, POLE2, PRIM1, PRIM2, RFC1, RFC2, RFC3, RFC4, RFC5, RPA1, RPA2, RPA3, RPA4, UBA52, UBC]	FALSE
WP:477	WikiPathways_09.11.2015	Cytoplasmic Ribosomal Proteins	[-1]	[Group9]	1	1.1235955	1.0	1.0	{Group9=1.0}	{Group9=1.0}	[RPL13A]	[FAU, LOC101929876, MRPL19, RPL10, RPL10A, RPL11, RPL12, RPL13, RPL13A, RPL14, RPL15, RPL17, RPL18, RPL18A, RPL19, RPL21, RPL22, RPL23, RPL23A, RPL24, RPL26, RPL27, RPL27A, RPL28, RPL29, RPL3, RPL30, RPL31, RPL32, RPL34, RPL35, RPL35A, RPL36, RPL36A, RPL37, RPL37A, RPL38, RPL39, RPL3L, RPL4, RPL41, RPL5, RPL6, RPL7, RPL7A, RPL8, RPL9, RPLP0, RPLP1, RPLP2, RPS10, RPS11, RPS12, RPS13, RPS14, RPS15, RPS15A, RPS16, RPS17, RPS18, RPS19, RPS2, RPS20, RPS21, RPS23, RPS24, RPS25, RPS26, RPS27, RPS27A, RPS28, RPS29, RPS3, RPS3A, RPS4X, RPS4Y1, RPS5, RPS6, RPS6KA1, RPS6KA2, RPS6KA3, RPS6KA6, RPS6KB1, RPS6KB2, RPS7, RPS8, RPS9, RPSA, UBA52]	TRUE
WP:481	WikiPathways_09.11.2015	Insulin Signaling	[-1]	[Group10, Group14, Group18, Group29, Group31, Group33, Group34, Group36, Group47, Group48, Group52, Group64, Group66]	6	3.75	0.010603873243942838	0.78468662005177	{Group10=0.015320357032764444, Group14=0.003307743828384746, Group18=2.2676648782666833E-5, Group29=0.03040812164679128, Group31=0.18555280111792985, Group33=0.013749297939086429, Group34=0.023242299876161884, Group36=0.4341567002016995, Group47=0.005968472152834779, Group48=0.10903713332925667, Group52=0.12732028864491843, Group64=1.3778632235359839E-5, Group66=0.09528179928216532}	{Group10=0.6281346383433422, Group14=0.1587717037624678, Group18=0.0014059522245253437, Group29=1.0, Group31=1.0, Group33=0.57747051344163, Group34=0.9296919950464754, Group36=1.0, Group47=0.26858124687756507, Group48=1.0, Group52=1.0, Group64=8.680538308276698E-4, Group66=1.0}	[HRAS, MTOR, PIK3C3, PIK3CA, PRKAA1, PTEN]	[AKT1, AKT2, ARF1, ARF6, ARHGAP33, CAP1, CBL, CBLB, CBLC, CRK, CYTH3, EGR1, EHD1, EHD2, EIF4E, EIF4EBP1, ELK1, ENPP1, FLOT1, FLOT2, FOS, FOXO1, FOXO3, GAB1, GRB10, GRB14, GRB2, GSK3A, GSK3B, GYG1, GYS1, GYS2, HRAS, IGF1R, IKBKB, INPP4A, INPPL1, INSR, IRS1, IRS2, IRS4, JUN, KIF3A, KIF5B, LIPE, MAP2K1, MAP2K2, MAP2K3, MAP2K4, MAP2K5, MAP2K6, MAP2K7, MAP3K1, MAP3K10, MAP3K11, MAP3K12, MAP3K13, MAP3K14, MAP3K2, MAP3K3, MAP3K4, MAP3K5, MAP3K6, MAP3K7, MAP3K8, MAP3K9, MAP4K1, MAP4K2, MAP4K3, MAP4K4, MAP4K5, MAPK1, MAPK10, MAPK11, MAPK12, MAPK13, MAPK14, MAPK3, MAPK4, MAPK6, MAPK7, MAPK8, MAPK9, MINK1, MTOR, MYO1C, PDPK1, PFKL, PFKM, PIK3C2A, PIK3C2G, PIK3C3, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PIK3R3, PIK3R4, PPP1R3A, PRKAA1, PRKAA2, PRKCA, PRKCB, PRKCD, PRKCH, PRKCI, PRKCQ, PRKCZ, PTEN, PTPN1, PTPN11, PTPRF, RAB4A, RAC1, RAC2, RAF1, RAPGEF1, REG1A, RHEB, RHOJ, RHOQ, RPS6KA1, RPS6KA2, RPS6KA3, RPS6KA4, RPS6KA5, RPS6KA6, RPS6KB1, RPS6KB2, RRAD, SGK1, SGK2, SGK3, SH2B2, SHC1, SHC2, SHC3, SLC2A1, SLC2A4, SNAP23, SNAP25, SOCS1, SOCS3, SORBS1, SOS1, SOS2, SRF, STX4, STXBP1, STXBP2, STXBP3, STXBP4, TBC1D4, TRIB3, TSC1, TSC2, VAMP2, XBP1]	TRUE
WP:524	WikiPathways_09.11.2015	G13 Signaling Pathway	[-1]	[Group19, Group22, Group36, Group66, Group70]	1	2.5641026	0.3705393207519536	1.0	{Group19=1.0, Group22=0.11196305953800512, Group36=0.4341567002016995, Group66=0.09528179928216532, Group70=0.37553683169036156}	{Group19=1.0, Group22=1.0, Group36=1.0, Group66=1.0, Group70=1.0}	[PIK3CA]	[ARHGDIB, ARHGDIG, ARHGEF1, CALM1, CDC42, CFL1, CFL2, CIT, CYFIP1, DIAPH1, GNA13, IQGAP1, IQGAP2, LIMK1, LOC100505585, MAP3K4, MAPK10, MYBPH, MYL1, PAK3, PFN1, PIK3CA, PIK3CB, PIK3CD, PIK3R2, PIP4K2A, PKN1, PPP1CB, RAC1, RHOA, RHPN2, ROCK1, ROCK2, RPS6KB1, RTKN, SH3RF1, TNK2, WAS, WASL]	FALSE
WP:531	WikiPathways_09.11.2015	Mismatch repair	[-1]	[Group28]	3	33.333332	1.2300019237083406E-4	0.01242301942945424	{Group28=3.1293743276319113E-11}	{Group28=2.159268286066019E-9}	[MSH2, MSH6, POLD1]	[EXO1, LIG1, MLH1, MSH2, MSH6, PCNA, POLD1, RFC1, RPA1]	FALSE
WP:536	WikiPathways_09.11.2015	Calcium Regulation in the Cardiac Cell	[-1]	[Group35, Group59]	1	0.67114097	1.0	1.0	{Group35=0.3257975894079523, Group59=0.15417153306498815}	{Group35=1.0, Group59=1.0}	[GRK6]	[ADCY1, ADCY2, ADCY3, ADCY4, ADCY5, ADCY6, ADCY7, ADCY8, ADCY9, ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, ADRB3, ANXA6, ARRB1, ARRB2, ATP1A4, ATP1B1, ATP1B2, ATP1B3, ATP2A2, ATP2A3, ATP2B1, ATP2B2, ATP2B3, CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1E, CACNA1S, CACNB1, CACNB3, CALM1, CALM2, CALM3, CALR, CAMK1, CAMK2A, CAMK2B, CAMK2D, CAMK2G, CAMK4, CASQ1, CASQ2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, FKBP1A, FXYD2, GJA1, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJC1, GJC2, GJD2, GNA11, GNAI1, GNAI2, GNAI3, GNAO1, GNAQ, GNAS, GNAZ, GNB1, GNB2, GNB3, GNB4, GNB5, GNG11, GNG12, GNG13, GNG2, GNG3, GNG4, GNG5, GNG7, GNG8, GNGT1, GRK4, GRK5, GRK6, ITPR1, ITPR2, ITPR3, KCNB1, KCNJ3, KCNJ5, PKIA, PKIB, PKIG, PLCB3, PLN, PRKACA, PRKACB, PRKAR1A, PRKAR1B, PRKAR2A, PRKAR2B, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PRKCH, PRKCQ, PRKCZ, PRKD1, RGS1, RGS10, RGS11, RGS14, RGS16, RGS17, RGS18, RGS19, RGS2, RGS20, RGS3, RGS4, RGS5, RGS6, RGS7, RGS9, RYR1, RYR2, RYR3, SFN, SLC8A1, SLC8A3, YWHAB, YWHAE, YWHAG, YWHAH, YWHAQ, YWHAZ]	FALSE
WP:560	WikiPathways_09.11.2015	TGF Beta Signaling Pathway	[-1]	[Group1, Group12, Group20, Group27, Group41, Group48]	1	1.7857143	0.48616223927837937	1.0	{Group1=0.3422234010584369, Group12=0.2420215438602354, Group20=4.853337156445499E-4, Group27=0.003150245716997155, Group41=0.11610019037275422, Group48=0.10903713332925667}	{Group1=1.0, Group12=1.0, Group20=0.028149355507383896, Group27=0.15751228584985774, Group41=1.0, Group48=1.0}	[HRAS]	[BAMBI, BMP4, CREBBP, CTNNB1, EGF, ENG, EP300, FKBP1A, FOS, FOXH1, FST, HRAS, IFNG, INHBA, ITGB6, JAK1, JUN, LEF1, LEFTY1, LEFTY2, LIF, LOC100505984, LTBP1, MAPK3, MAPK9, MIR302A, NFKB1, NOG, RUNX2, RUNX3, SERPINE1, SKI, SKIL, SMAD1, SMAD2, SMAD3, SMAD4, SMAD5, SMAD6, SMAD7, SMAD9, SPP1, STAT1, STAT3, TFE3, TGFB1, TGFBR1, TGFBR2, TGFBR3, TGIF1, THBS1, TNF, WNT1, ZEB2, ZFYVE9, ZNF423]	FALSE
WP:585	WikiPathways_09.11.2015	Interferon type I signaling pathways	[-1]	[Group1, Group13, Group19, Group21, Group29, Group32, Group33, Group34, Group35, Group36, Group46, Group47, Group52, Group54, Group59, Group72, Group76]	2	3.7037036	0.13198073992097265	1.0	{Group1=0.3422234010584369, Group13=0.33292187912560667, Group19=1.0, Group21=0.060782830193602554, Group29=0.03040812164679128, Group32=0.04886948215445072, Group33=0.013749297939086429, Group34=0.023242299876161884, Group35=0.3257975894079523, Group36=0.4341567002016995, Group46=0.013359738966869447, Group47=0.005968472152834779, Group52=0.12732028864491843, Group54=0.2887596066788072, Group59=0.15417153306498815, Group72=0.004865643191837814, Group76=0.4084685652197573}	{Group1=1.0, Group13=1.0, Group19=1.0, Group21=1.0, Group29=1.0, Group32=1.0, Group33=0.57747051344163, Group34=0.9296919950464754, Group35=1.0, Group36=1.0, Group46=0.5744687755753862, Group47=0.26858124687756507, Group52=1.0, Group54=1.0, Group59=1.0, Group72=0.22381958682453945, Group76=1.0}	[CREB1, MTOR]	[CBL, CREB1, CRK, CRKL, EIF4A1, EIF4B, EIF4E, EIF4EBP1, FYN, GAB2, GNB2L1, IFNAR1, IFNAR2, IRF9, IRS1, IRS2, JAK1, LCK, MAP2K3, MAP2K6, MAP3K1, MAPK14, MAPKAP1, MLST8, MTOR, PDCD4, PIAS1, PIAS3, PIK3CD, PIK3R1, PIK3R2, PRMT1, PTPN11, PTPN6, PTPRC, RAC1, RAP1A, RAPGEF1, REL, RPS6, RPS6KA4, RPS6KA5, RPS6KB1, RPTOR, SOCS1, SOCS3, STAT1, STAT2, STAT3, STAT4, STAT5A, TYK2, VAV1, ZAP70]	FALSE
WP:615	WikiPathways_09.11.2015	Senescence and Autophagy in Cancer	[-1]	[Group10, Group14, Group41, Group46, Group48]	5	4.7619047	0.00741161674963514	0.5706944897219057	{Group10=0.015320357032764444, Group14=0.003307743828384746, Group41=0.11610019037275422, Group46=0.013359738966869447, Group48=0.10903713332925667}	{Group10=0.6281346383433422, Group14=0.1587717037624678, Group41=1.0, Group46=0.5744687755753862, Group48=1.0}	[HRAS, IL6ST, MTOR, PIK3C3, PTEN]	[AKT1S1, AMBRA1, ATG10, ATG12, ATG13, ATG14, ATG16L1, ATG3, ATG5, ATG7, BCL2, BECN1, BMI1, BMP2, BRAF, CCL3, CD44, CDC25B, CDKN1A, CDKN1B, CDKN2A, CEBPB, COL10A1, COL1A1, COL3A1, CREG1, CXCL1, CXCL14, CXCL8, E2F1, FKBP8, FN1, GABARAP, GABARAPL1, GABARAPL2, GSK3B, GSN, HMGA1, HRAS, IFI16, IFNB1, IFNG, IGF1, IGF1R, IGFBP3, IGFBP5, IGFBP7, IL1A, IL1B, IL24, IL3, IL6, IL6R, IL6ST, ING1, ING2, INHBA, INS, IRF1, IRF5, IRF7, JUN, KMT2A, LAMP1, LAMP2, MAP1LC3A, MAP1LC3B, MAP1LC3C, MAP2K1, MAP2K3, MAPK1, MAPK14, MDM2, MLST8, MMP14, MTOR, PCNA, PIK3C3, PLAT, PLAU, PTEN, RAF1, RB1, RB1CC1, RNASEL, RSL1D1, SERPINB2, SERPINE1, SH3GLB1, SLC39A1, SLC39A2, SLC39A3, SLC39A4, SMAD3, SMAD4, SPARC, SQSTM1, SRC, TGFB1, THBS1, TNFSF15, TP53, ULK1, UVRAG, VTN]	TRUE
WP:666	WikiPathways_09.11.2015	Hypothetical Network for Drug Addiction	[-1]	[Group1, Group13, Group16, Group19, Group21, Group35, Group41, Group43, Group59, Group6, Group76]	1	3.125	0.3158180874997565	1.0	{Group1=0.3422234010584369, Group13=0.33292187912560667, Group16=1.0, Group19=1.0, Group21=0.060782830193602554, Group35=0.3257975894079523, Group41=0.11610019037275422, Group43=0.27638591509599, Group59=0.15417153306498815, Group6=0.0018572031677458632, Group76=0.4084685652197573}	{Group1=1.0, Group13=1.0, Group16=1.0, Group19=1.0, Group21=1.0, Group35=1.0, Group41=1.0, Group43=1.0, Group59=1.0, Group6=0.09843176789053075, Group76=1.0}	[CREB1]	[ACTA1, ADCY1, ADCY8, CAMK2B, CAMK4, CREB1, DRD1, DRD2, DRD4, GJB7, GRIA1, GRIA2, GRIA3, GRIA4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRM1, GRM5, KRIT1, MAP2K1, MAP2K2, MAPK1, MAPK3, NISCH, PPA1, PRKACA, PRKCE, TERF2IP, ZHX2]	FALSE
WP:673	WikiPathways_09.11.2015	ErbB Signaling Pathway	[-1]	[Group15, Group20, Group27, Group32, Group34, Group4, Group46, Group48, Group53, Group57, Group68]	5	9.090909	4.169258873052581E-4	0.040441811068610035	{Group15=5.47972669334322E-4, Group20=4.853337156445499E-4, Group27=0.003150245716997155, Group32=0.04886948215445072, Group34=0.023242299876161884, Group4=2.3359082094591414E-6, Group46=0.013359738966869447, Group48=0.10903713332925667, Group53=6.567096321826248E-4, Group57=2.7626465873397032E-5, Group68=3.328030031465086E-4}	{Group15=0.03068646948272203, Group20=0.028149355507383896, Group27=0.15751228584985774, Group32=1.0, Group34=0.9296919950464754, Group4=1.4949812540538505E-4, Group46=0.5744687755753862, Group48=1.0, Group53=0.036119029770044365, Group57=0.001685214418277219, Group68=0.01963537718564401}	[ABL1, HRAS, KRAS, MTOR, PTK2]	[ABL1, AKT3, ARAF, AREG, BAD, BCL2L11, BTC, CAMK2A, CBLC, CCND1, CDKN1A, CDKN1B, CRK, EGF, EGFR, EIF4EBP1, ELK1, ERBB2, ERBB3, ERBB4, EREG, FOXO1, GAB1, GRB2, GSK3B, HBEGF, HRAS, JUN, KRAS, MAP2K1, MAP2K7, MAPK1, MAPK8, MDM2, MIR21, MTOR, MYC, NCK1, NRG1, NRG2, NRG3, NRG4, PAK4, PDK1, PIK3R5, PLCG1, PRKCA, PTK2, RPS6KB1, SHC2, SOS1, SRC, STAT5A, TGFA, TP53]	TRUE
WP:691	WikiPathways_09.11.2015	Tamoxifen metabolism	[-1]	[Group24]	1	4.7619047	0.22025027072627276	1.0	{Group24=0.7890042018472335}	{Group24=1.0}	[CYP2D6]	[CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP2E1, CYP3A4, CYP3A5, FMO1, FMO3, SULT1A1, SULT1E1, SULT2A1, UGT1A10, UGT1A4, UGT1A8, UGT2B15, UGT2B7]	FALSE
WP:702	WikiPathways_09.11.2015	Metapathway biotransformation	[-1]	[Group24]	1	0.5555556	0.7238533677322825	1.0	{Group24=0.7890042018472335}	{Group24=1.0}	[CYP2D6]	[AKR1A1, AKR1B1, AKR1B10, AKR1C1, AKR1C2, AKR1C3, AKR1C4, AKR1D1, AKR7A2, AKR7A3, BAAT, CHST1, CHST10, CHST11, CHST12, CHST13, CHST14, CHST2, CHST3, CHST4, CHST5, CHST6, CHST7, CHST8, CHST9, COMT, CYP11A1, CYP11B1, CYP11B2, CYP17A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP20A1, CYP21A2, CYP24A1, CYP26A1, CYP26B1, CYP26C1, CYP27A1, CYP27B1, CYP27C1, CYP2A13, CYP2A7, CYP2B6, CYP2C18, CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP2E1, CYP2F1, CYP2J2, CYP2R1, CYP2S1, CYP2U1, CYP2W1, CYP39A1, CYP3A4, CYP3A43, CYP3A5, CYP3A7, CYP3A7-CYP3A51P, CYP46A1, CYP4B1, CYP4F11, CYP4F12, CYP4F2, CYP4F22, CYP4F3, CYP4F8, CYP4V2, CYP4X1, CYP4Z1, CYP51A1, CYP7A1, CYP7B1, CYP8B1, EPHX1, EPHX2, FMO1, FMO2, FMO3, FMO4, FMO5, GAL3ST1, GAL3ST2, GAL3ST3, GAL3ST4, GLYAT, GLYATL1, GLYATL2, GPX2, GPX3, GPX4, GSR, GSS, GSTA3, GSTA4, GSTA5, GSTCD, GSTK1, GSTM1, GSTM2, GSTM3, GSTM4, GSTM5, GSTO1, GSTO2, GSTP1, GSTT2, GSTT2B, GSTZ1, HNMT, HS2ST1, HS3ST1, HS3ST2, HS3ST3A1, HS3ST3B1, HS3ST4, HS3ST6, HS6ST1, HS6ST2, HS6ST3, KCNAB1, KCNAB2, KCNAB3, LOC100287413, LOC101927181, LOC105369243, MGST1, MGST2, MGST3, NAA20, NAA30, NAA40, NAA50, NAT10, NAT14, NAT2, NAT8, NAT8L, NAT9, NDST1, NDST2, NDST3, NDST4, NNMT, SLX1A-SULT1A3, SLX1B-SULT1A4, SULT1A1, SULT1A2, SULT1A4, SULT1B1, SULT1C2, SULT1C3, SULT1C4, SULT1E1, SULT2A1, SULT2B1, SULT4A1, SULT6B1, TPMT, UGT1A1, UGT1A10, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A9, UGT2A1, UGT2A2, UGT2A3, UGT2B11, UGT2B17, UGT2B28, UGT2B4, UGT2B7]	FALSE
WP:706	WikiPathways_09.11.2015	SIDS Susceptibility Pathways	[-1]	[Group16, Group21]	3	1.875	0.43627390627560403	1.0	{Group16=1.0, Group21=0.060782830193602554}	{Group16=1.0, Group21=1.0}	[CREB1, HSPD1, PBX1]	[ACADM, ADCYAP1, ADCYAP1R1, ALDOA, AQP4, AR, ASCL1, ATP1A3, AVP, BDNF, BHLHE40, C4A, C4B, CASP3, CAV3, CC2D1A, CDCA7L, CEBPB, CHAT, CHRM2, CHRNA4, CHRNA7, CHRNB2, CHRNB4, CPT1A, CREB1, CREBBP, CREM, CTCF, CTNNB1, CXCL8, DDC, DEAF1, DLX2, ECE1, EGR1, EN1, EP300, ESR2, FEV, FMO3, FOXM1, G6PC, GABRA1, GAPDH, GATA2, GATA3, GCK, GJA1, GNB3, GPD1L, GRIN1, HADHA, HADHB, HDAC1, HDAC9, HES1, HES5, HIF1A, HSP90B1, HSPD1, HTR1A, HTR2A, HTR3A, IL10, IL13, IL1A, IL1B, IL1RN, IL6, IL6R, JUN, KCNH2, KCNJ8, KCNQ1, LMX1B, LOC102723788, MAOA, MAP2, MAZ, MBD1, MECP2, MEF2C, MIR130A, MIR16-1, MIR210, MYB, NANOG, NEUROD1, NFKB1, NFKB2, NFYA, NGF, NKX2-2, NKX3-1, NOS1AP, NR3C1, NTRK2, PAH, PBX1, PHOX2A, PHOX2B, PKNOX1, PLP1, POU2F2, POU3F2, POU5F1, PPARGC1A, PPARGC1B, PRKACA, PRKACB, PRKAR1A, PRKAR1B, PRKAR2A, PRKAR2B, REST, RET, RORA, RUNX3, RYR2, SCN3B, SCN4B, SCN5A, SLC1A3, SLC25A4, SLC6A4, SLC9A3, SNAP25, SNTA1, SOX2, SP1, SP3, SPTBN1, SST, SSTR1, SSTR2, TAC1, TACR1, TCF3, TF, TH, THRB, TLX3, TNF, TP73, TPH1, TPH2, TPPP, TSPYL1, VAMP2, VEGFA, VIPR1, VIPR2, YBX1, YWHAB, YWHAE, YWHAG, YWHAH, YWHAQ, YWHAZ]	FALSE
WP:707	WikiPathways_09.11.2015	DNA Damage Response	[-1]	[Group17, Group25, Group30, Group51, Group6]	9	13.235294	6.423099740020886E-8	7.0654097140229745E-6	{Group17=6.776241579089485E-11, Group25=0.0014192920911883721, Group30=2.972243278064436E-11, Group51=5.751852119082846E-12, Group6=0.0018572031677458632}	{Group17=4.607844273780849E-9, Group25=0.0766417729241721, Group30=2.080570294645105E-9, Group51=4.083815004548821E-10, Group6=0.09843176789053075}	[ABL1, ATM, BID, BRCA1, CREB1, PRKDC, RAD50, RAD51, TNFRSF10B]	[ABL1, APAF1, ATM, ATR, ATRIP, BAX, BBC3, BID, BRCA1, CASP3, CASP8, CASP9, CCNB1, CCNB2, CCNB3, CCND1, CCND2, CCND3, CCNE1, CCNE2, CDC25A, CDC25C, CDK1, CDK2, CDK4, CDK5, CDK6, CDKN1A, CDKN1B, CHEK1, CHEK2, CREB1, CYCS, DDB2, E2F1, FANCD2, FAS, GADD45A, GADD45B, GADD45G, H2AFX, HUS1B, MDM2, MRE11A, MYC, NBN, PIDD1, PMAIP1, PML, PRKDC, RAD1, RAD17, RAD50, RAD51, RAD52, RAD9A, RB1, RFC1, RPA2, RRM2B, SESN1, SFN, SMC1A, TLK1, TLK2, TNFRSF10B, TP53, TP53AIP1]	TRUE
WP:710	WikiPathways_09.11.2015	DNA Damage Response (only ATM dependent)	[-1]	[Group10, Group11, Group18, Group20, Group37, Group4, Group53, Group57, Group64, Group68]	8	7.207207	3.7986460330536925E-5	0.0038746189537147663	{Group10=0.015320357032764444, Group11=0.0020227372439293166, Group18=2.2676648782666833E-5, Group20=4.853337156445499E-4, Group37=7.113870981722735E-7, Group4=2.3359082094591414E-6, Group53=6.567096321826248E-4, Group57=2.7626465873397032E-5, Group64=1.3778632235359839E-5, Group68=3.328030031465086E-4}	{Group10=0.6281346383433422, Group11=0.10518233668432446, Group18=0.0014059522245253437, Group20=0.028149355507383896, Group37=4.624016138119778E-5, Group4=1.4949812540538505E-4, Group53=0.036119029770044365, Group57=0.001685214418277219, Group64=8.680538308276698E-4, Group68=0.01963537718564401}	[ABL1, ATM, HRAS, KRAS, NRAS, PIK3C3, PIK3CA, PTEN]	[ABL1, AKT1, AKT2, AKT3, APC, ATM, AXIN1, BAD, BAK1, BAX, BBC3, BCL2, BCL2L11, BCL6, BIK, CAT, CCND1, CCND2, CCND3, CCNG2, CDC42, CDKN1A, CDKN1B, CDKN2A, CTNNB1, DVL1, DVL2, DVL3, ERBB2, FASLG, FOSL1, FOXO3, FRAT1, G6PC, GRB2, GSK3B, HMGB1, HRAS, INSR, IRS1, JUN, KRAS, LDLR, LEF1, LOC100129518, LOC101929777, MAP3K1, MAP3K4, MAP3K7, MAPK1, MAPK10, MAPK8, MAPK9, MDM2, MLKL, MYC, NFKB1, NFKB2, NRAS, PCK2, PDK1, PIK3C2A, PIK3C2B, PIK3C2G, PIK3C3, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PIK3R3, PIK3R4, PLAU, PMAIP1, PPP2R5C, PPP2R5E, PTEN, RAC1, RAC2, RAC3, RBL2, RHOA, SCP2, SHC1, SMAD3, SMAD4, SOD2, SOS1, SOS2, TCF7, TCF7L1, TCF7L2, TGFB1, TP53, TP73, WNT1, WNT10A, WNT10B, WNT11, WNT16, WNT2, WNT2B, WNT3, WNT3A, WNT4, WNT5A, WNT5B, WNT6, WNT7A, WNT7B]	TRUE
WP:712	WikiPathways_09.11.2015	Estrogen signaling pathway	[-1]	[Group1, Group13, Group19, Group21, Group22, Group29, Group33, Group36, Group59, Group76]	2	8.695652	0.029316568799164153	1.0	{Group1=0.3422234010584369, Group13=0.33292187912560667, Group19=1.0, Group21=0.060782830193602554, Group22=0.11196305953800512, Group29=0.03040812164679128, Group33=0.013749297939086429, Group36=0.4341567002016995, Group59=0.15417153306498815, Group76=0.4084685652197573}	{Group1=1.0, Group13=1.0, Group19=1.0, Group21=1.0, Group22=1.0, Group29=1.0, Group33=0.57747051344163, Group36=1.0, Group59=1.0, Group76=1.0}	[CREB1, PIK3CA]	[AKT1, BCL2, BRAF, CHUK, CREB1, ELK1, ESR1, FOS, GNAS, GNB1, GNGT1, GPER1, IKBKB, IKBKG, JUN, MAP2K1, MAPK1, MAPK14, MAPK9, NFKB1, PIK3CA, PRKACA, SP1]	FALSE
WP:732	WikiPathways_09.11.2015	Serotonin Receptor 2 and ELK-SRF/GATA4 signaling	[-1]	[Group11, Group12, Group15, Group18, Group20, Group37, Group46, Group53, Group57, Group68, Group74]	3	15.0	0.001522740573754065	0.13704665163786584	{Group11=0.0020227372439293166, Group12=0.2420215438602354, Group15=5.47972669334322E-4, Group18=2.2676648782666833E-5, Group20=4.853337156445499E-4, Group37=7.113870981722735E-7, Group46=0.013359738966869447, Group53=6.567096321826248E-4, Group57=2.7626465873397032E-5, Group68=3.328030031465086E-4, Group74=0.5483333906310934}	{Group11=0.10518233668432446, Group12=1.0, Group15=0.03068646948272203, Group18=0.0014059522245253437, Group20=0.028149355507383896, Group37=4.624016138119778E-5, Group46=0.5744687755753862, Group53=0.036119029770044365, Group57=0.001685214418277219, Group68=0.01963537718564401, Group74=1.0}	[HRAS, KRAS, NRAS]	[ELK1, ELK4, GATA4, GNAQ, HRAS, HTR2A, HTR2B, HTR2C, ITPR1, KRAS, MAP2K1, MAP2K2, MAPK1, MAPK3, MAPKAPK2, NRAS, RAF1, RASGRF1, RASGRP1, SRF]	TRUE
WP:734	WikiPathways_09.11.2015	Serotonin Receptor 4/6/7 and NR3C Signaling	[-1]	[Group1, Group13, Group16, Group19, Group21, Group35, Group41, Group43, Group59, Group6, Group76]	1	5.263158	0.20151722510892747	1.0	{Group1=0.3422234010584369, Group13=0.33292187912560667, Group16=1.0, Group19=1.0, Group21=0.060782830193602554, Group35=0.3257975894079523, Group41=0.11610019037275422, Group43=0.27638591509599, Group59=0.15417153306498815, Group6=0.0018572031677458632, Group76=0.4084685652197573}	{Group1=1.0, Group13=1.0, Group16=1.0, Group19=1.0, Group21=1.0, Group35=1.0, Group41=1.0, Group43=1.0, Group59=1.0, Group6=0.09843176789053075, Group76=1.0}	[CREB1]	[ATF1, BRAF, CREB1, EGR1, ELK1, ELK4, GNAS, HTR4, HTR6, HTR7, MAP2K1, MAP2K2, MAPK1, MAPK3, MAPKAPK2, NR3C1, RAP1A, RPS6KA5, SRF]	FALSE
WP:1403	WikiPathways_09.11.2015	AMPK Signaling	[-1]	[Group0, Group10, Group29, Group31, Group33, Group36, Group47, Group52]	4	5.7971015	0.008410233571405279	0.6391777514268012	{Group0=0.023577362178657905, Group10=0.015320357032764444, Group29=0.03040812164679128, Group31=0.18555280111792985, Group33=0.013749297939086429, Group36=0.4341567002016995, Group47=0.005968472152834779, Group52=0.12732028864491843}	{Group0=0.9195171249676584, Group10=0.6281346383433422, Group29=1.0, Group31=1.0, Group33=0.57747051344163, Group36=1.0, Group47=0.26858124687756507, Group52=1.0}	[MTOR, PIK3C3, PIK3CA, PRKAA1]	[ACACA, ACACB, ADIPOQ, ADIPOR1, ADIPOR2, ADRA1A, ADRA1B, AKT1, AKT2, CAB39, CAMKK1, CAMKK2, CCNA1, CCNA2, CCNB1, CDKN1A, CPT1A, CPT1B, CPT1C, CRTC2, EEF2, EEF2K, EIF4EBP1, ELAVL1, FASN, GYS1, GYS2, HMGCR, HNF4A, INS-IGF2, INSR, LEP, LEPR, LIPE, LOC101930123, MEF2BNB-MEF2B, MTOR, PFKFB3, PIK3C3, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PIK3R3, PLCB1, PPARGC1B, PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKACB, PRKACG, PRKAG1, PRKAG2, PRKAG3, RPS6KB1, RPS6KB2, RPTOR, SLC2A4, SLC2A4RG, SREBF1, STK11, STRADA, STRADB, TP53, TSC1, TSC2]	TRUE
WP:1422	WikiPathways_09.11.2015	Sphingolipid Metabolism	[-1]	[Group40]	1	5.0	0.21093836321090575	1.0	{Group40=0.21093836321090575}	{Group40=1.0}	[SERINC1]	[ASAH1, ASAH2, B4GALT6, CERK, CERS2, CERS3, CERS4, CERS5, CERS6, GAL3ST1, KDSR, PLPP1, SERINC1, SGMS2, SGPP2, SPHK1, SPHK2, SPTLC1, SPTLC2, SPTLC3]	TRUE
WP:1449	WikiPathways_09.11.2015	Regulation of toll-like receptor signaling pathway	[-1]	[Group19, Group22, Group36, Group66, Group70]	1	0.7092199	1.0	1.0	{Group19=1.0, Group22=0.11196305953800512, Group36=0.4341567002016995, Group66=0.09528179928216532, Group70=0.37553683169036156}	{Group19=1.0, Group22=1.0, Group36=1.0, Group66=1.0, Group70=1.0}	[PIK3CA]	[AKT1, AKT2, AKT3, BTK, CASP8, CCL3, CCL4, CCL5, CD14, CD180, CD40, CD80, CD86, CHUK, CISH, CTNNAL1, CUEDC2, CXCL10, CXCL11, CXCL8, CXCL9, CYLD, FADD, FBXW5, FOS, IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8, IFNAR1, IFNAR2, IFNB1, IKBKB, IKBKE, IKBKG, IL12A, IL12B, IL1B, IL6, IRAK1, IRAK2, IRAK3, IRAK4, IRF3, IRF5, IRF7, JUN, LBP, LY96, MAP2K1, MAP2K2, MAP2K3, MAP2K4, MAP2K6, MAP2K7, MAP3K7, MAP3K8, MAPK1, MAPK10, MAPK11, MAPK12, MAPK13, MAPK14, MAPK3, MAPK8, MAPK9, MBL2, MIR105-1, MIR98, MLST8, MYD88, NFKB1, NFKB2, NFKBIA, OTUD5, PELI1, PELI2, PELI3, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PIK3R3, PIK3R5, PLK1, PTPN6, RAC1, RBCK1, RELA, RIPK1, RNF216, RNF31, RNF41, SARM1, SFTPA2, SFTPD, SIGIRR, SMAD6, SOCS1, SPP1, SQSTM1, STAT1, SYK, TAB1, TAB2, TAB3, TBK1, TICAM1, TICAM2, TIFA, TIRAP, TLR1, TLR2, TLR3, TLR4, TLR5, TLR6, TLR7, TLR8, TLR9, TMED7, TNF, TNFAIP3, TOLLIP, TRAF3, TRAF6, TRAFD1, TREM1, USP7, ZMYND11]	TRUE
WP:1471	WikiPathways_09.11.2015	TOR Signaling	[-1]	[Group10, Group13, Group29, Group31, Group32, Group34, Group36, Group47, Group52, Group54, Group72]	2	5.5555553	0.06628716678722593	1.0	{Group10=0.015320357032764444, Group13=0.33292187912560667, Group29=0.03040812164679128, Group31=0.18555280111792985, Group32=0.04886948215445072, Group34=0.023242299876161884, Group36=0.4341567002016995, Group47=0.005968472152834779, Group52=0.12732028864491843, Group54=0.2887596066788072, Group72=0.004865643191837814}	{Group10=0.6281346383433422, Group13=1.0, Group29=1.0, Group31=1.0, Group32=1.0, Group34=0.9296919950464754, Group36=1.0, Group47=0.26858124687756507, Group52=1.0, Group54=1.0, Group72=0.22381958682453945}	[MTOR, PRKAA1]	[AKT1, AKT1S1, CDC42, DDIT4, DDIT4L, EIF4EBP1, FKBP1A, HMGCR, IDI1, MAPKAP1, MLST8, MTOR, PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKAG1, PRKAG2, PRKAG3, PRKCA, PRR5, PRR5L, RAC1, RHEB, RICTOR, RPS6KB1, RPTOR, RRAGA, RRAGB, RRAGC, RRAGD, TSC1, TSC2, ULK1, ULK2, ULK3]	TRUE
WP:1528	WikiPathways_09.11.2015	Physiological and Pathological Hypertrophy  of the Heart	[-1]	[Group0, Group50, Group54, Group56, Group71, Group73, Group76]	2	8.333333	0.03174398709346369	1.0	{Group0=0.023577362178657905, Group50=0.3398859873930151, Group54=0.2887596066788072, Group56=0.3398859873930151, Group71=0.257855130160565, Group73=0.09588739026439713, Group76=0.4084685652197573}	{Group0=0.9195171249676584, Group50=1.0, Group54=1.0, Group56=1.0, Group71=1.0, Group73=1.0, Group76=1.0}	[IL6ST, PPP3CA]	[AGT, CALM1, CAMK2D, CTF1, EDN1, FOS, GATA4, IL6ST, JUN, LIFR, MAP2K3, MAPK1, MAPK11, MAPK14, MAPK8, MYEF2, NFATC4, PPP3CA, PPP3CB, PRKCB, PRKCE, RAC1, RHOA, STAT3]	TRUE
WP:1530	WikiPathways_09.11.2015	miRNA Regulation of DNA Damage Response	[-1]	[Group17, Group25, Group30, Group51, Group6]	9	10.4651165	5.095514547059432E-7	5.4012454198829986E-5	{Group17=6.776241579089485E-11, Group25=0.0014192920911883721, Group30=2.972243278064436E-11, Group51=5.751852119082846E-12, Group6=0.0018572031677458632}	{Group17=4.607844273780849E-9, Group25=0.0766417729241721, Group30=2.080570294645105E-9, Group51=4.083815004548821E-10, Group6=0.09843176789053075}	[ABL1, ATM, BID, BRCA1, CREB1, PRKDC, RAD50, RAD51, TNFRSF10B]	[ABL1, APAF1, ATM, ATR, ATRIP, BAX, BBC3, BID, BRCA1, CASP3, CASP8, CASP9, CCNB1, CCNB2, CCNB3, CCND1, CCND2, CCND3, CCNE1, CCNE2, CCNG1, CDC20B, CDC25A, CDC25C, CDK1, CDK2, CDK4, CDK5, CDK6, CDKN1A, CDKN1B, CHEK1, CHEK2, CREB1, CYCS, DDB2, E2F1, FANCD2, FAS, GADD45A, GADD45B, GADD45G, H2AFX, HUS1B, MCM7, MDM2, MIR106B, MIR16-1, MIR17HG, MIR181A1, MIR203A, MIR21, MIR210, MIR221, MIR222, MIR223, MIR3074, MIR330, MIR373, MIR449A, MIR449B, MRE11A, MYC, NBN, PIDD1, PMAIP1, PML, PRKDC, RAD1, RAD17, RAD50, RAD51, RAD52, RAD9A, RB1, RFC1, RPA2, RRM2B, SESN1, SFN, SMC1A, TLK1, TLK2, TNFRSF10B, TP53, TP53AIP1]	TRUE
WP:1539	WikiPathways_09.11.2015	Angiogenesis	[-1]	[Group11, Group22, Group64, Group67, Group70]	3	12.5	0.002614967561387368	0.22488721027931366	{Group11=0.0020227372439293166, Group22=0.11196305953800512, Group64=1.3778632235359839E-5, Group67=0.11782420498332685, Group70=0.37553683169036156}	{Group11=0.10518233668432446, Group22=1.0, Group64=8.680538308276698E-4, Group67=1.0, Group70=1.0}	[FLT1, PIK3CA, PTK2]	[AKT1, ANGPT1, ARNT, CREBBP, FGF2, FGFR2, FLT1, HIF1A, KDR, MAPK1, MAPK14, MMP9, NOS3, PDGFB, PDGFRA, PIK3CA, PLCG1, PTK2, SMAD1, SRC, TEK, TIMP2, TIMP3, VEGFA]	TRUE
WP:1544	WikiPathways_09.11.2015	MicroRNAs in cardiomyocyte hypertrophy	[-1]	[Group0, Group29, Group33, Group36, Group54, Group56]	4	4.0816326	0.02736635552582614	1.0	{Group0=0.023577362178657905, Group29=0.03040812164679128, Group33=0.013749297939086429, Group36=0.4341567002016995, Group54=0.2887596066788072, Group56=0.3398859873930151}	{Group0=0.9195171249676584, Group29=1.0, Group33=0.57747051344163, Group36=1.0, Group54=1.0, Group56=1.0}	[IL6ST, MTOR, PIK3CA, PPP3CA]	[AGT, AKT1, AKT2, CALM1, CAMK2D, CDK7, CDK9, CHUK, CISH, CTF1, CTNNB1, DVL1, EDN1, EGF, EIF2B5, FGF2, FGFR2, FZD1, FZD2, GATA4, GSK3B, HDAC4, HDAC5, HDAC7, HDAC9, IGF1, IGF1R, IKBKB, IKBKE, IKBKG, IL6ST, LIF, LRP5, LRP6, MAP2K1, MAP2K2, MAP2K3, MAP2K4, MAP2K5, MAP2K6, MAP2K7, MAP3K14, MAPK1, MAPK14, MAPK3, MAPK4, MAPK7, MAPK8, MIR103A1, MIR103A2, MIR125B1, MIR125B2, MIR130B, MIR133A2, MIR133B, MIR140, MIR15B, MIR199A1, MIR199A2, MIR21, MIR214, MIR23A, MIRLET7B, MTOR, MYEF2, MYLK, MYLK3, NFATC4, NFKB1, NPPA, NPPB, NRG1, PDPK1, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PIK3R3, PLA2G2A, PLCB2, PPP3CA, PPP3CB, PRKCB, PRKG1, RAC1, RAF1, RCAN1, RHOA, ROCK1, ROCK2, STAT3, TAB1, TGFB1, TNF, WNT3A, WNT5A]	TRUE
WP:1545	WikiPathways_09.11.2015	miRNAs involved in DNA damage response	[-1]	[Group17, Group21, Group25, Group51, Group6, Group69]	3	6.976744	0.013622071489720519	0.9944112187495979	{Group17=6.776241579089485E-11, Group21=0.060782830193602554, Group25=0.0014192920911883721, Group51=5.751852119082846E-12, Group6=0.0018572031677458632, Group69=0.006439583968393921}	{Group17=4.607844273780849E-9, Group21=1.0, Group25=0.0766417729241721, Group51=4.083815004548821E-10, Group6=0.09843176789053075, Group69=0.2833416946093325}	[ABL1, ATM, CREB1]	[ABL1, ATM, CCND1, CCND3, CCNE1, CDC25A, CDK6, CDKN1A, CDKN1B, CREB1, E2F1, H2AFX, MIR100, MIR106B, MIR143, MIR15B, MIR16-1, MIR181A1, MIR181B1, MIR203A, MIR21, MIR210, MIR221, MIR222, MIR223, MIR23A, MIR23B, MIR25, MIR27A, MIR3074, MIR330, MIR371A, MIR372, MIR373, MIR449A, MIR449B, MIR449C, MIR503, MIR93, MIRLET7B, MYC, RAD52, TP53]	FALSE
WP:1584	WikiPathways_09.11.2015	Type II diabetes mellitus	[-1]	[Group13, Group31, Group32, Group35, Group36, Group48, Group52, Group54, Group72]	1	4.5454545	0.22945419173789686	1.0	{Group13=0.33292187912560667, Group31=0.18555280111792985, Group32=0.04886948215445072, Group35=0.3257975894079523, Group36=0.4341567002016995, Group48=0.10903713332925667, Group52=0.12732028864491843, Group54=0.2887596066788072, Group72=0.004865643191837814}	{Group13=1.0, Group31=1.0, Group32=1.0, Group35=1.0, Group36=1.0, Group48=1.0, Group52=1.0, Group54=1.0, Group72=0.22381958682453945}	[MTOR]	[ADIPOQ, CACNA1A, GK, IKBKB, INS-IGF2, INSR, IRS1, KCNJ11, MAFA, MAPK1, MAPK8, MTOR, PDX1, PHKA2, PIK3R5, PRKCD, PRKCZ, SLC2A2, SLC2A4, SOCS4, SURF1, TNF]	TRUE
WP:1589	WikiPathways_09.11.2015	Folate-Alcohol and Cancer Pathway	[-1]	[Group1, Group13, Group16, Group19, Group21, Group35, Group41, Group43, Group59, Group6, Group76]	1	11.111111	0.10101419993906365	1.0	{Group1=0.3422234010584369, Group13=0.33292187912560667, Group16=1.0, Group19=1.0, Group21=0.060782830193602554, Group35=0.3257975894079523, Group41=0.11610019037275422, Group43=0.27638591509599, Group59=0.15417153306498815, Group6=0.0018572031677458632, Group76=0.4084685652197573}	{Group1=1.0, Group13=1.0, Group16=1.0, Group19=1.0, Group21=1.0, Group35=1.0, Group41=1.0, Group43=1.0, Group59=1.0, Group6=0.09843176789053075, Group76=1.0}	[CREB1]	[ADH5, ALDH1A1, ALDH1L1, CBS, CBSL, CEBPB, CREB1, CYP2E1, MTHFR]	TRUE
WP:1601	WikiPathways_09.11.2015	Fluoropyrimidine Activity	[-1]	[Group23]	4	12.121212	5.444571305329108E-4	0.052267884531159436	{Group23=5.444571305329108E-4}	{Group23=0.031034056440375914}	[ABCC4, ABCG2, RRM1, SLC29A1]	[ABCC3, ABCC4, ABCC5, ABCG2, CDA, CES1, CES2, CYP2A6, DHFR, DPYD, DPYS, ERCC2, FPGS, GGH, MTHFR, PPAT, RRM1, RRM2, SLC22A7, SLC29A1, SMUG1, TDG, TK1, TP53, TYMP, TYMS, UCK1, UCK2, UMPS, UPB1, UPP1, UPP2, XRCC3]	TRUE
WP:1604	WikiPathways_09.11.2015	Codeine and Morphine Metabolism	[-1]	[Group24, Group38, Group63]	2	25.0	0.003631481035176439	0.297781444884468	{Group24=0.7890042018472335, Group38=0.8126859102118735, Group63=0.296656766532177}	{Group24=1.0, Group38=1.0, Group63=1.0}	[ABCB1, CYP2D6]	[ABCB1, ABCC2, ABCC3, CYP2D6, CYP3A4, SLCO1B1, UGT1A1, UGT2B7]	TRUE
WP:1742	WikiPathways_09.11.2015	TP53 Network	[-1]	[Group17, Group25, Group51, Group6, Group69, Group75]	3	15.789474	0.0013051638149440565	0.11876990715990914	{Group17=6.776241579089485E-11, Group25=0.0014192920911883721, Group51=5.751852119082846E-12, Group6=0.0018572031677458632, Group69=0.006439583968393921, Group75=0.12156046396649858}	{Group17=4.607844273780849E-9, Group25=0.0766417729241721, Group51=4.083815004548821E-10, Group6=0.09843176789053075, Group69=0.2833416946093325, Group75=1.0}	[ABL1, ATM, BID]	[ABL1, ATM, BAX, BBC3, BCL2, BID, BOK, CDKN1A, CDKN2A, GADD45A, MDM2, MYC, OTX2, PMAIP1, SUMO1, TNFSF10, TP53, TP63, TP73]	TRUE
WP:1772	WikiPathways_09.11.2015	Apoptosis Modulation and Signaling	[-1]	[Group50, Group75]	2	2.2222223	0.28573961578523677	1.0	{Group50=0.3398859873930151, Group75=0.12156046396649858}	{Group50=1.0, Group75=1.0}	[BID, TNFRSF10B]	[AIFM1, AIFM2, APAF1, BAD, BAG3, BAK1, BAX, BBC3, BCL2, BCL2A1, BCL2L1, BCL2L10, BCL2L11, BCL2L2, BID, BIK, BIRC2, BIRC3, BIRC5, BIRC6, BIRC7, BLK, BMF, BOK, CAPNS1, CASP1, CASP10, CASP2, CASP3, CASP4, CASP6, CASP7, CASP8, CASP9, CDKN2A, CFLAR, CRADD, CYCS, DAXX, DFFA, DFFB, DIABLO, ENDOG, FADD, FAS, FASLG, FOS, HN1, HRK, HSPA1A, HTRA2, IKBKB, IL1R1, IL1R2, IRAK1, JUN, MADD, MAP3K14, MAP3K5, MAPK3, MAPK8, MCL1, MYD88, NAIP, NFKB1, NFKBIA, PEA15, PIDD1, PMAIP1, PRKD1, PTPN13, PTRH2, RIPK1, SEPT4, TNFRSF10A, TNFRSF10B, TNFRSF10C, TNFRSF10D, TNFRSF11B, TNFRSF1A, TNFRSF1B, TNFRSF25, TNFRSF6B, TNFSF10, TOLLIP, TP53, TRADD, TRAF3, TRAF6, XIAP]	TRUE
WP:1971	WikiPathways_09.11.2015	Integrated Cancer pathway	[-1]	[Group28, Group30, Group37, Group61]	6	13.043478	1.312648141564079E-5	0.0013520275858110015	{Group28=3.1293743276319113E-11, Group30=2.972243278064436E-11, Group37=7.113870981722735E-7, Group61=3.758262700808551E-9}	{Group28=2.159268286066019E-9, Group30=2.080570294645105E-9, Group37=4.624016138119778E-5, Group61=2.518036009541729E-7}	[ATM, BRCA1, MSH2, MSH6, PTEN, RAD50]	[AKT1, ATF1, ATM, ATR, BACH1, BAD, BARD1, BAX, BBC3, BCL2, BLM, BRCA1, CASP3, CASP8, CASP9, CDC25A, CDC25B, CDK1, CDK2, CDK4, CDKN1A, CDKN1B, CDKN2B, CHEK1, CHEK2, E2F1, GRIK1-AS2, JAK1, MAP3K5, MDM2, MIR21, MMP1, MRE11A, MSH2, MSH6, MYC, NOXA1, PLK1, POU2F1, PTEN, RAD50, RB1, SMAD2, SMAD3, STAT1, TP53]	TRUE
WP:1982	WikiPathways_09.11.2015	SREBP signalling	[-1]	[Group0, Group10, Group13, Group19, Group29, Group31, Group33, Group34, Group35, Group36, Group47, Group52]	4	5.633803	0.00929024804250836	0.6967686031881271	{Group0=0.023577362178657905, Group10=0.015320357032764444, Group13=0.33292187912560667, Group19=1.0, Group29=0.03040812164679128, Group31=0.18555280111792985, Group33=0.013749297939086429, Group34=0.023242299876161884, Group35=0.3257975894079523, Group36=0.4341567002016995, Group47=0.005968472152834779, Group52=0.12732028864491843}	{Group0=0.9195171249676584, Group10=0.6281346383433422, Group13=1.0, Group19=1.0, Group29=1.0, Group31=1.0, Group33=0.57747051344163, Group34=0.9296919950464754, Group35=1.0, Group36=1.0, Group47=0.26858124687756507, Group52=1.0}	[CREB1, MTOR, PIK3CA, PRKAA1]	[ACACA, ACLY, ACSS1, AKT1, AMFR, ATF6, CAMP, CDK8, CREB1, CYP51A1, DBI, FASN, FDFT1, FDPS, FGF21, GPAM, GSK3A, HMGCR, HMGCS1, IDI1, INS, INSIG1, INSIG2, KPNB1, LDLR, LPIN1, LPL, LSS, MBTPS1, MBTPS2, MDH1, MED15, MIR33A, MIR33B, MTOR, MVD, NFYA, NR1H2, PIK3CA, PPARG, PPARGC1B, PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKACA, PRKAG1, PRKAG2, PRKAG3, RBP4, RNF139, SAR1A, SAR1B, SCAP, SCARB1, SCD, SEC13, SEC23A, SEC23B, SEC24A, SEC24B, SEC24C, SEC24D, SEC31A, SEC31B, SIRT1, SP1, SQLE, SREBF1, SREBF2, YY1]	TRUE
WP:1984	WikiPathways_09.11.2015	Integrated Breast Cancer Pathway	[-1]	[Group17, Group28, Group30, Group37, Group4, Group51]	14	9.210526	1.1665159212186952E-9	1.2948326725527517E-7	{Group17=6.776241579089485E-11, Group28=3.1293743276319113E-11, Group30=2.972243278064436E-11, Group37=7.113870981722735E-7, Group4=2.3359082094591414E-6, Group51=5.751852119082846E-12}	{Group17=4.607844273780849E-9, Group28=2.159268286066019E-9, Group30=2.080570294645105E-9, Group37=4.624016138119778E-5, Group4=1.4949812540538505E-4, Group51=4.083815004548821E-10}	[ABL1, ATM, AURKA, BID, BRCA1, BRCA2, CREB1, KRAS, MSH2, MSH6, MTOR, PTEN, RAD50, RAD51]	[ABL1, AHR, AKT1, ALKBH1, ANXA1, APOBEC3G, AR, ARAF, ATF1, ATM, ATR, AURKA, BACH1, BAD, BAK1, BARD1, BAX, BCL2, BID, BLM, BMPR1A, BMPR2, BRAF, BRCA1, BRCA2, CASP3, CASP8, CASP9, CCNB1IP1, CCND1, CDC25A, CDC25B, CDC42, CDH1, CDK2, CDK4, CDK7, CERK, CHEK1, CHEK2, CHUK, CREB1, CSNK1D, CTNNB1, CYP19A1, DAG1, DCAKD, DHTKD1, E2F1, EDAR, EGFR, EP300, ERAL1, ESR1, FADD, FAU, FER, FILIP1, FOSL1, FOXO1, GADD45A, GDI1, GRIK1-AS2, GRN, GSK3A, HDAC1, HIPK2, HMGCR, IMPA1, IRS1, ITPKC, JAK1, JAKMIP1, JUN, KRAS, LGALS13, MAP3K13, MAP3K7CL, MAPK1, MAX, MDM2, MIR21, MMP1, MRE11A, MSH2, MSH6, MTOR, MYC, MYCBP2, MYT1, NAB1, NCOA3, NF1, NFKB1, NOXA1, NUP85, ODC1, PAK1, PHB, PIAS1, PIGR, PIK3R2, PKIA, PLK1, PLK3, PML, PPP4R3A, PTEN, RAC1, RAD50, RAD51, RAD54L, RALA, RALGAPA1, RAP1A, RASGEF1A, RASGRP3, RB1, RHEB, RHO, RPP38, RRAS, SIRT1, SMAD1, SMAD2, SMAD4, SMAD6, SMAD7, SMARCA4, SP1, STAT1, STK11, TAB1, TFPI, TGFBR1, TGFBR2, TP53, TPR, TRADD, TSC1, TSC2, UBE2F, USP15, USP16, USP21, USP38, VEGFA, WEE1, XRCC3, ZMIZ1, ZMYND8, ZNF655]	TRUE
WP:2011	WikiPathways_09.11.2015	SREBF and miR33 in cholesterol and lipid homeostasis	[-1]	[Group10, Group29, Group31, Group34, Group47, Group52, Group58, Group72]	3	16.666666	0.0011082892463496123	0.10196261066416433	{Group10=0.015320357032764444, Group29=0.03040812164679128, Group31=0.18555280111792985, Group34=0.023242299876161884, Group47=0.005968472152834779, Group52=0.12732028864491843, Group58=0.04294071628232707, Group72=0.004865643191837814}	{Group10=0.6281346383433422, Group29=1.0, Group31=1.0, Group34=0.9296919950464754, Group47=0.26858124687756507, Group52=1.0, Group58=1.0, Group72=0.22381958682453945}	[MTOR, PPARA, PRKAA1]	[ABCA1, FASN, HMGCR, HMGCS1, LDLR, MED15, MIR33A, MIR33B, MTOR, NR1H3, PPARA, PPARGC1A, PRKAA1, SCD, SIRT1, SIRT6, SREBF1, SREBF2]	TRUE
WP:2012	WikiPathways_09.11.2015	miRs in Muscle Cell Differentiation	[-1]	[Group60]	1	2.7027028	0.3553593036357793	1.0	{Group60=1.0}	{Group60=1.0}	[EZH2]	[ELSPBP1, EZH2, ID2, MEF2A, MEF2B, MEF2C, MEF2D, MIR1-1, MIR133A2, MIR133B, MIR214, MIR221, MIR222, MIR26A1, MIR26A2, MYF5, MYOD1, PAX7, PRKACA, PRKACB, PRKACG, PRKAR1A, PRKAR1B, PRKAR2A, PRKAR2B, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PRKCH, PRKCI, PRKCQ, PRKCZ, PRKD1, PRKD3, SRF]	TRUE
WP:2018	WikiPathways_09.11.2015	RANKL/RANK Signaling Pathway	[-1]	[Group13, Group15, Group27, Group32, Group34, Group36, Group48, Group52, Group54, Group67, Group72]	2	3.6363637	0.1359710915145359	1.0	{Group13=0.33292187912560667, Group15=5.47972669334322E-4, Group27=0.003150245716997155, Group32=0.04886948215445072, Group34=0.023242299876161884, Group36=0.4341567002016995, Group48=0.10903713332925667, Group52=0.12732028864491843, Group54=0.2887596066788072, Group67=0.11782420498332685, Group72=0.004865643191837814}	{Group13=1.0, Group15=0.03068646948272203, Group27=0.15751228584985774, Group32=1.0, Group34=0.9296919950464754, Group36=1.0, Group48=1.0, Group52=1.0, Group54=1.0, Group67=1.0, Group72=0.22381958682453945}	[MTOR, PTK2]	[ACP5, AKT1, AKT2, CALCR, CBL, CDC42, CHUK, CTSK, FHL2, FOS, GAB2, ICAM1, IKBKB, IKBKG, JUN, LYN, MAP2K1, MAP2K6, MAP2K7, MAP3K7, MAPK1, MAPK14, MAPK3, MAPK8, MAPK9, MITF, MTOR, NFATC1, NFKB1, NFKB2, NFKBIA, PAPSS2, PIK3R1, PIK3R2, PLCG1, PTK2, RAC1, RELA, RELB, SPI1, SQSTM1, SRC, STAT1, SYK, TAB1, TAB2, TNFRSF11A, TNFRSF11B, TNFSF11, TRAF1, TRAF2, TRAF3, TRAF5, TRAF6, VCAM1]	TRUE
WP:2032	WikiPathways_09.11.2015	TSH signaling pathway	[-1]	[Group0, Group1, Group10, Group13, Group19, Group29, Group33, Group34, Group35, Group36, Group4, Group41, Group46, Group47, Group48, Group57, Group64]	4	6.060606	0.007196051148622177	0.5612919895925298	{Group0=0.023577362178657905, Group1=0.3422234010584369, Group10=0.015320357032764444, Group13=0.33292187912560667, Group19=1.0, Group29=0.03040812164679128, Group33=0.013749297939086429, Group34=0.023242299876161884, Group35=0.3257975894079523, Group36=0.4341567002016995, Group4=2.3359082094591414E-6, Group41=0.11610019037275422, Group46=0.013359738966869447, Group47=0.005968472152834779, Group48=0.10903713332925667, Group57=2.7626465873397032E-5, Group64=1.3778632235359839E-5}	{Group0=0.9195171249676584, Group1=1.0, Group10=0.6281346383433422, Group13=1.0, Group19=1.0, Group29=1.0, Group33=0.57747051344163, Group34=0.9296919950464754, Group35=1.0, Group36=1.0, Group4=1.4949812540538505E-4, Group41=1.0, Group46=0.5744687755753862, Group47=0.26858124687756507, Group48=1.0, Group57=0.001685214418277219, Group64=8.680538308276698E-4}	[CREB1, HRAS, MTOR, PIK3CA]	[ADCY2, ADCY3, AKT1, APEX1, BRAF, CCND3, CCNE1, CDK2, CDK4, CDKN1B, CGA, CREB1, E2F1, EGR1, FOS, GNA12, GNA13, GNAI1, GNAI2, GNAI3, GNAO1, GNAQ, GNAS, GNB1, GNG2, HRAS, IGF1R, JAK1, JAK2, JUN, KCNIP3, MAP2K1, MAP2K3, MAP2K6, MAPK1, MAPK14, MAPK3, MTOR, MYC, MYL12B, PAX8, PDE4D, PDPK1, PIK3CA, PIK3R1, PIK3R2, PLCB1, PLD1, RAF1, RALGDS, RAP1A, RAP1B, RAP1GAP, RB1, RBL2, RPS6, RPS6KA1, RPS6KB1, SCRIB, SRC, STAT1, STAT3, TSHB, TSHR, TTF1, TTF2]	TRUE
WP:2034	WikiPathways_09.11.2015	Leptin signaling pathway	[-1]	[Group1, Group10, Group13, Group15, Group27, Group29, Group31, Group32, Group33, Group34, Group35, Group4, Group41, Group46, Group47, Group48, Group52]	5	6.6666665	0.001730198232092897	0.15398764265626783	{Group1=0.3422234010584369, Group10=0.015320357032764444, Group13=0.33292187912560667, Group15=5.47972669334322E-4, Group27=0.003150245716997155, Group29=0.03040812164679128, Group31=0.18555280111792985, Group32=0.04886948215445072, Group33=0.013749297939086429, Group34=0.023242299876161884, Group35=0.3257975894079523, Group4=2.3359082094591414E-6, Group41=0.11610019037275422, Group46=0.013359738966869447, Group47=0.005968472152834779, Group48=0.10903713332925667, Group52=0.12732028864491843}	{Group1=1.0, Group10=0.6281346383433422, Group13=1.0, Group15=0.03068646948272203, Group27=0.15751228584985774, Group29=1.0, Group31=1.0, Group32=1.0, Group33=0.57747051344163, Group34=0.9296919950464754, Group35=1.0, Group4=1.4949812540538505E-4, Group41=1.0, Group46=0.5744687755753862, Group47=0.26858124687756507, Group48=1.0, Group52=1.0}	[CREB1, HRAS, MTOR, PRKAA1, PTK2]	[ACACA, ACACB, AKT1, BAD, BAX, BCL2L1, CCND1, CDC42, CFL2, CHUK, CISH, CREB1, EIF4E, EIF4EBP1, ELK1, ERBB2, ESR1, FOXO1, FYN, GRB2, GSK3A, GSK3B, HRAS, IKBKB, IKBKG, IL1B, IL1RN, IRS1, JAK1, JAK2, KHDRBS1, KPNA4, LEP, LEPR, MAP2K1, MAP2K2, MAPK1, MAPK14, MAPK3, MAPK8, MTOR, NCOA1, NFKB1, NOS3, PDE3B, PIK3R1, PIK3R2, PLCG1, PLCG2, PRKAA1, PRKAA2, PTK2, PTPN1, PTPN11, RAC1, RAF1, REL, RELA, RHOA, ROCK1, ROCK2, RPS6, RPS6KA1, RPS6KB1, SH2B1, SHC1, SOCS2, SOCS3, SOCS7, SOS1, SP1, SRC, STAT1, STAT3, STAT5B]	TRUE
WP:2035	WikiPathways_09.11.2015	FSH signaling pathway	[-1]	[Group13, Group21, Group29, Group33, Group34, Group35, Group42, Group46, Group47, Group59, Group72]	3	11.111111	0.0036859469944624554	0.29856170655145886	{Group13=0.33292187912560667, Group21=0.060782830193602554, Group29=0.03040812164679128, Group33=0.013749297939086429, Group34=0.023242299876161884, Group35=0.3257975894079523, Group42=0.09746363511951099, Group46=0.013359738966869447, Group47=0.005968472152834779, Group59=0.15417153306498815, Group72=0.004865643191837814}	{Group13=1.0, Group21=1.0, Group29=1.0, Group33=0.57747051344163, Group34=0.9296919950464754, Group35=1.0, Group42=1.0, Group46=0.5744687755753862, Group47=0.26858124687756507, Group59=1.0, Group72=0.22381958682453945}	[CREB1, GRK6, MTOR]	[AKT1, APPL1, AREG, BDNF, CGA, CREB1, CYP19A1, EIF4EBP1, FOXO1, FSHB, FSHR, GRK6, HIST3H3, MAPK1, MAPK14, MAPK3, MTOR, PRKACA, PRKCA, RAF1, RHEB, RPS6, RPS6KB1, RPS6KB2, SGK1, SRC, TSC2]	TRUE
WP:2038	WikiPathways_09.11.2015	Regulation of Microtubule Cytoskeleton	[-1]	[Group18, Group64, Group66]	4	8.695652	0.0019384940199393466	0.17058747375466252	{Group18=2.2676648782666833E-5, Group64=1.3778632235359839E-5, Group66=0.09528179928216532}	{Group18=0.0014059522245253437, Group64=8.680538308276698E-4, Group66=1.0}	[ABL1, MAPRE1, PIK3CA, PTEN]	[ABL1, AKT1, APC, AURKB, CAMK4, CDC42, CDK1, CFL2, CLASP1, CLIP1, DIAPH1, DPYSL2, DVL1, EPHB2, F2RL2, GNAQ, GSK3B, KIF2C, LIMK1, MAP1B, MAPKAPK2, MAPRE1, MAPT, MARK1, MARK2, PAK1, PARD6A, PHLDB2, PIK3CA, PRKACA, PRKCA, PTEN, PTPRA, RAC1, RHO, ROCK1, SPRED1, SRC, STAT3, STMN1, TAOK1, TESK2, TIAM1, TPPP, TRIO, WNT3A]	TRUE
WP:2059	WikiPathways_09.11.2015	Alzheimers Disease	[-1]	[Group50, Group54, Group56, Group71, Group75, Group76]	2	1.6806723	0.6508147725891527	1.0	{Group50=0.3398859873930151, Group54=0.2887596066788072, Group56=0.3398859873930151, Group71=0.257855130160565, Group75=0.12156046396649858, Group76=0.4084685652197573}	{Group50=1.0, Group54=1.0, Group56=1.0, Group71=1.0, Group75=1.0, Group76=1.0}	[BID, PPP3CA]	[ADAM10, ADAM17, APAF1, APBB1, APH1A, APOE, APP, ATF6, ATP2A1, ATP2A2, ATP2A3, BACE1, BAD, BID, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CALM1, CALM2, CALM3, CALML3, CALML5, CAPN1, CAPN2, CASP12, CASP3, CASP7, CASP8, CASP9, CDK5, CDK5R1, CHP1, CHP2, CYCS, EIF2AK3, ERN1, FADD, FAS, GAPDH, GNAQ, GRIN1, GRIN2A, GRIN2C, GRIN2D, GSK3B, HSD17B10, IDE, IL1B, ITPR1, ITPR2, ITPR3, LPL, LRP1, MAPK1, MAPK3, MAPT, MIR101-1, MIR10A, MIR124-1, MIR124-2, MIR124-3, MIR125A, MIR125B1, MIR1285-2, MIR129-1, MIR1307, MIR132, MIR134, MIR135A1, MIR135A2, MIR138-1, MIR139, MIR181A1, MIR181A2, MIR181B1, MIR181B2, MIR181D, MIR182, MIR184, MIR199B, MIR21, MIR218-1, MIR218-2, MIR219A2, MIR219B, MIR29B1, MIR3176, MIR326, MIR329-2, MIR33B, MIR431, MIR671, MIR708, MIR769, MIR9-2, MIR9-3, MIR95, MME, NAE1, NCSTN, NOS1, PLCB1, PLCB2, PLCB3, PLCB4, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, PSEN1, PSEN2, PSENEN, RYR3, SNCA, TNF, TNFRSF1A, TP53]	TRUE
WP:2203	WikiPathways_09.11.2015	TSLP Signaling Pathway	[-1]	[Group0, Group10, Group13, Group19, Group22, Group29, Group32, Group33, Group36, Group52, Group54, Group72]	2	4.255319	0.10491445045645867	1.0	{Group0=0.023577362178657905, Group10=0.015320357032764444, Group13=0.33292187912560667, Group19=1.0, Group22=0.11196305953800512, Group29=0.03040812164679128, Group32=0.04886948215445072, Group33=0.013749297939086429, Group36=0.4341567002016995, Group52=0.12732028864491843, Group54=0.2887596066788072, Group72=0.004865643191837814}	{Group0=0.9195171249676584, Group10=0.6281346383433422, Group13=1.0, Group19=1.0, Group22=1.0, Group29=1.0, Group32=1.0, Group33=0.57747051344163, Group36=1.0, Group52=1.0, Group54=1.0, Group72=0.22381958682453945}	[MTOR, PIK3CA]	[AKT1, BTK, CCL11, CISH, CRLF2, CXCL8, EIF4EBP1, FES, FYN, GAB2, HCK, IL2RA, IL6, IL7R, JAK1, JAK2, LCK, LYN, MAP2K1, MAP2K2, MAPK1, MAPK14, MAPK3, MAPK8, MAPK9, MTOR, MYC, NFKB1, NFKB2, NFKBIA, PI4K2A, PIK3CA, PTPN11, RELA, RELB, RPS6, SRC, STAT1, STAT3, STAT4, STAT5A, STAT5B, STAT6, TEC, TNFSF4, TSLP, YES1]	TRUE
WP:2261	WikiPathways_09.11.2015	Signaling Pathways in Glioblastoma	[-1]	[Group18, Group20, Group28, Group30, Group37, Group53, Group57, Group64, Group68]	9	10.843373	3.7421031819606484E-7	4.0040504046978936E-5	{Group18=2.2676648782666833E-5, Group20=4.853337156445499E-4, Group28=3.1293743276319113E-11, Group30=2.972243278064436E-11, Group37=7.113870981722735E-7, Group53=6.567096321826248E-4, Group57=2.7626465873397032E-5, Group64=1.3778632235359839E-5, Group68=3.328030031465086E-4}	{Group18=0.0014059522245253437, Group20=0.028149355507383896, Group28=2.159268286066019E-9, Group30=2.080570294645105E-9, Group37=4.624016138119778E-5, Group53=0.036119029770044365, Group57=0.001685214418277219, Group64=8.680538308276698E-4, Group68=0.01963537718564401}	[ATM, BRCA1, BRCA2, HRAS, KRAS, MSH6, NRAS, PIK3CA, PTEN]	[AKT1, AKT2, AKT3, ARAF, ATM, BRAF, BRCA1, BRCA2, CBL, CCND1, CCND2, CCNE1, CDK2, CDK4, CDK6, CDKN1A, CDKN1B, CDKN2A, CDKN2B, CDKN2C, E2F1, EGFR, EP300, ERBB2, ERBB3, ERRFI1, FGFR1, FGFR2, FOXO1, FOXO3, FOXO4, GAB1, GRB2, HRAS, IGF1R, IRS1, KRAS, MAP2K1, MAP2K2, MAP2K3, MAP2K4, MAP2K5, MAP2K6, MAP2K7, MAPK1, MAPK3, MDM2, MDM4, MET, MIR21, MSH6, NF1, NRAS, PDGFRA, PDGFRB, PDPK1, PIK3C2A, PIK3C2B, PIK3C2G, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PLCG1, PLCG2, PRKCA, PRKCB, PRKCD, PRKCG, PRKCH, PRKCI, PRKCQ, PRKCZ, PTEN, RAF1, RB1, SPRY2, SRC, TP53, TSC1, TSC2]	TRUE
WP:2272	WikiPathways_09.11.2015	Pathogenic Escherichia coli infection	[-1]	[Group25, Group6]	1	1.8181819	0.4799805692973874	1.0	{Group25=0.0014192920911883721, Group6=0.0018572031677458632}	{Group25=0.0766417729241721, Group6=0.09843176789053075}	[ABL1]	[ABL1, ACTB, ACTG1, ARHGEF2, ARPC1A, ARPC1B, ARPC2, ARPC3, ARPC4, ARPC5, ARPC5L, CD14, CDC42, CDH1, CLDN1, CTNNB1, CTTN, EZR, FYN, HCLS1, ITGB1, KRT18, LY96, NCK1, NCK2, NCL, OCLN, PRKCA, RHOA, ROCK1, ROCK2, TLR4, TLR5, TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBA8, TUBAL3, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8, WAS, WASL, YWHAQ, YWHAZ]	FALSE
WP:2289	WikiPathways_09.11.2015	Drug Induction of Bile Acid Pathway	[-1]	[Group24, Group38, Group63]	2	11.764706	0.016482801012167654	1.0	{Group24=0.7890042018472335, Group38=0.8126859102118735, Group63=0.296656766532177}	{Group24=1.0, Group38=1.0, Group63=1.0}	[ABCB1, ABCC4]	[ABCB1, ABCB11, ABCC2, ABCC3, ABCC4, BAAT, CYP3A4, CYP7A1, NR1H4, NR1I2, NR1I3, SLC10A1, SLC51A, SLC51B, SLCO1B1, SULT2A1, VDR]	TRUE
WP:2290	WikiPathways_09.11.2015	RalA downstream regulated genes	[-1]	[Group11, Group12, Group15, Group18, Group20, Group37, Group46, Group53, Group57, Group68, Group74]	3	25.0	3.141577841706959E-4	0.031101620632898893	{Group11=0.0020227372439293166, Group12=0.2420215438602354, Group15=5.47972669334322E-4, Group18=2.2676648782666833E-5, Group20=4.853337156445499E-4, Group37=7.113870981722735E-7, Group46=0.013359738966869447, Group53=6.567096321826248E-4, Group57=2.7626465873397032E-5, Group68=3.328030031465086E-4, Group74=0.5483333906310934}	{Group11=0.10518233668432446, Group12=1.0, Group15=0.03068646948272203, Group18=0.0014059522245253437, Group20=0.028149355507383896, Group37=4.624016138119778E-5, Group46=0.5744687755753862, Group53=0.036119029770044365, Group57=0.001685214418277219, Group68=0.01963537718564401, Group74=1.0}	[HRAS, KRAS, NRAS]	[CDC42, EXOC2, EXOC8, HRAS, KRAS, NRAS, RAC1, RAC2, RAC3, RALA, RALBP1, YBX3]	TRUE
WP:2328	WikiPathways_09.11.2015	Allograft Rejection	[-1]	[Group24, Group38, Group63]	1	1.2658228	0.6099928930970131	1.0	{Group24=0.7890042018472335, Group38=0.8126859102118735, Group63=0.296656766532177}	{Group24=1.0, Group38=1.0, Group63=1.0}	[ABCB1]	[ABCB1, AGTR1, BHMT2, C3, C4A, C5, CASP3, CASP7, CASP8, CASP9, CCL19, CCL21, CD28, CD40, CD40LG, CD80, CD86, COL5A1, CSNK2A2, CTLA4, CXCL11, CXCL12, CXCL13, CXCL8, CXCL9, CXCR5, FAS, FASLG, FOXP3, GABPA, GDNF, GNLY, GZMB, HARS, HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB5, HLA-E, HLA-F, HLA-G, IFNG, IL10, IL12A, IL12B, IL13, IL17A, IL1A, IL1B, IL2, IL21, IL22, IL2RA, IL4, IL5, LOC105369230, LRRK2, MICA, PDGFRA, PECR, PRF1, PRKCZ, STAT1, TGFB1, TNF, TUBA1B, VEGFA, VIM]	TRUE
WP:2332	WikiPathways_09.11.2015	Interleukin-11 Signaling Pathway	[-1]	[Group1, Group12, Group14, Group21, Group33, Group34, Group41, Group43, Group46, Group47, Group73]	3	6.818182	0.014498739438161875	1.0	{Group1=0.3422234010584369, Group12=0.2420215438602354, Group14=0.003307743828384746, Group21=0.060782830193602554, Group33=0.013749297939086429, Group34=0.023242299876161884, Group41=0.11610019037275422, Group43=0.27638591509599, Group46=0.013359738966869447, Group47=0.005968472152834779, Group73=0.09588739026439713}	{Group1=1.0, Group12=1.0, Group14=0.1587717037624678, Group21=1.0, Group33=0.57747051344163, Group34=0.9296919950464754, Group41=1.0, Group43=1.0, Group46=0.5744687755753862, Group47=0.26858124687756507, Group73=1.0}	[CREB1, HRAS, IL6ST]	[AKT1, ATF1, BCL2, BGLAP, BIRC5, CHUK, CREB1, FES, FYN, GRB2, HRAS, IBSP, ICAM1, IKBKB, IL11, IL11RA, IL6ST, ITGA2, JAK1, JAK2, MAP2K1, MAP2K2, MAPK1, MAPK3, PDPK1, PIAS1, PIAS3, PIK3R1, PIK3R2, PPP2R4, PTPN11, RAF1, RELA, RPS6, RPS6KA1, RPS6KB1, RUNX2, SOCS3, SRC, STAT1, STAT3, TGFB1, TYK2, YES1]	TRUE
WP:2355	WikiPathways_09.11.2015	Corticotropin-releasing hormone	[-1]	[Group26, Group35, Group42, Group59]	4	4.347826	0.022288569017630936	1.0	{Group26=1.6750572661729398E-4, Group35=0.3257975894079523, Group42=0.09746363511951099, Group59=0.15417153306498815}	{Group26=0.010050343597037638, Group35=1.0, Group42=1.0, Group59=1.0}	[CREB1, GRK6, PARP1, PTK2]	[ACACA, ADRBK2, AKT1, ARRB1, ARRB2, BCL2, BRAF, CACNA1H, CAMK2A, CASP12, CASP3, CASP9, CREB1, CRH, CRHBP, CRHR1, CRHR2, CTNNB1, CXCL8, CYP11A1, CYP11B1, CYP21A2, ECE1, ELK1, ERN1, FOS, FOSB, FOSL1, FOSL2, GJA1, GNA11, GNAI1, GNAI2, GNAO1, GNAQ, GNAS, GNAZ, GNB1, GNB2, GNB3, GNB5, GRK6, GSK3B, HSD3B1, HSD3B2, HSP90AA1, IL18, IL2, IVL, JUNB, JUND, JUP, KRT1, KRT14, MAP2K1, MAP3K5, MAPK1, MAPK14, MAPK3, MAPK8, MAPK9, NCOA2, NFKB1, NFKBIA, NOS3, NR4A1, NR4A2, PARP1, PLCG1, PLCG2, POMC, PRKAA2, PRKCA, PRKCB, PRKCD, PRKCI, PRKCQ, PTK2, RAF1, RAP1B, RAPGEF3, RELA, RHOA, SP1, STAR, SULT2A1, TBX19, TCF4, TFAP2A, TGFB1, TLR4, TRIM28]	TRUE
WP:2361	WikiPathways_09.11.2015	Gastric Cancer Network 1	[-1]	[Group44]	2	6.8965516	0.04499033432385519	1.0	{Group44=0.04499033432385519}	{Group44=1.0}	[AURKA, KIF20B]	[ACTL6A, APC, AURKA, C21orf33, CCNA1, CENPF, CEP192, E2F7, ECT2, ESM1, GATS, H3F3A, HIST4H4, INO80D, KIF15, KIF20B, LIN9, LOC102724023, MCM4, MYBL2, NOTCH1, NUP107, RNF216, RUVBL1, S100P, SMOC2, TOP2A, TPX2, UBE2C]	TRUE
WP:2369	WikiPathways_09.11.2015	Histone Modifications	[-1]	[Group60]	1	2.0408163	0.4413265394440571	1.0	{Group60=1.0}	{Group60=1.0}	[EZH2]	[AEBP2, ASH1L, DOT1L, EED, EHMT1, EHMT2, EZH1, EZH2, H3F3A, H3F3B, HIST1H3D, HIST1H3J, HIST1H4C, HIST1H4H, HIST1H4J, HIST2H3A, HIST2H3C, HIST2H3D, HIST4H4, KMT2A, KMT2C, KMT2D, KMT2E, KMT5A, KMT5B, KMT5C, NSD1, PRDM2, SET, SETBP1, SETD1A, SETD1B, SETD2, SETD3, SETD4, SETD5, SETD6, SETD7, SETD9, SETDB1, SETDB2, SETMAR, SMYD1, SMYD2, SMYD3, SMYD4, SMYD5, SUV39H1, SUV39H2]	FALSE
WP:2371	WikiPathways_09.11.2015	Parkinsons Disease Pathway	[-1]	[Group45]	1	1.8181819	0.4799805692973874	1.0	{Group45=0.4799805692973874}	{Group45=1.0}	[SYT11]	[APAF1, ATXN2, CASP2, CASP3, CASP6, CASP7, CASP9, CCNE1, CCNE2, CYCS, DDC, EPRS, GPR37, HTRA2, LRRK2, MAPK11, MAPK12, MAPK13, MAPK14, MIR10A, MIR1224, MIR128-2, MIR1294, MIR132, MIR16-2, MIR195, MIR19A, MIR19B1, MIR19B2, MIR212, MIR26A1, MIR26A2, MIR30A, MIR431, MIR4448, MIR503, PARK2, PARK7, PINK1, SEPT5, SLC6A3, SNCA, SNCAIP, SYT11, TH, UBA1, UBA7, UBB, UBE2G1, UBE2G2, UBE2J1, UBE2J2, UBE2L3, UBE2L6, UCHL1]	TRUE
WP:2374	WikiPathways_09.11.2015	Oncostatin M Signaling Pathway	[-1]	[Group1, Group13, Group14, Group15, Group20, Group33, Group34, Group35, Group4, Group41, Group43, Group46, Group47, Group48, Group57]	5	7.6923075	9.053210269800251E-4	0.08419485550914234	{Group1=0.3422234010584369, Group13=0.33292187912560667, Group14=0.003307743828384746, Group15=5.47972669334322E-4, Group20=4.853337156445499E-4, Group33=0.013749297939086429, Group34=0.023242299876161884, Group35=0.3257975894079523, Group4=2.3359082094591414E-6, Group41=0.11610019037275422, Group43=0.27638591509599, Group46=0.013359738966869447, Group47=0.005968472152834779, Group48=0.10903713332925667, Group57=2.7626465873397032E-5}	{Group1=1.0, Group13=1.0, Group14=0.1587717037624678, Group15=0.03068646948272203, Group20=0.028149355507383896, Group33=0.57747051344163, Group34=0.9296919950464754, Group35=1.0, Group4=1.4949812540538505E-4, Group41=1.0, Group43=1.0, Group46=0.5744687755753862, Group47=0.26858124687756507, Group48=1.0, Group57=0.001685214418277219}	[CREB1, HRAS, IL6ST, KRAS, MTOR]	[AKT1, CASP3, CASP7, CCL2, CDK2, CDKN1B, CEBPB, CREB1, CYR61, EGR1, FOS, GRB2, HIF1A, HRAS, IL6ST, IRS1, JAK1, JAK2, JAK3, JUNB, JUND, KRAS, LDLR, LIFR, MAP2K1, MAP2K2, MAPK1, MAPK14, MAPK3, MAPK8, MAPK9, MMP1, MMP13, MMP3, MTOR, NFKB1, NFKBIA, OSM, OSMR, PIAS3, PIK3R1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCH, PTK2B, PTPN11, PXN, RAF1, RELA, RICTOR, RPS6, SERPINE1, SHC1, SOCS3, SOS1, SRC, STAT1, STAT3, STAT5B, TIMP3, TP53, TYK2, VEGFA]	TRUE
WP:2377	WikiPathways_09.11.2015	Integrated Pancreatic Cancer Pathway	[-1]	[Group17, Group30, Group51]	16	8.333333	2.714398130613448E-10	3.040125906287062E-8	{Group17=6.776241579089485E-11, Group30=2.972243278064436E-11, Group51=5.751852119082846E-12}	{Group17=4.607844273780849E-9, Group30=2.080570294645105E-9, Group51=4.083815004548821E-10}	[ABCB1, ABL1, ATM, BID, BRCA1, BRCA2, CREB1, EZH2, HSP90AB1, KRAS, PIK3CA, PTEN, RAD50, RAD51, RRM1, SMO]	[ABCB1, ABL1, ACHE, AGPAT2, AKT1, ANXA1, APAF1, APC, APP, AR, ARF1, ATM, BAD, BAX, BBC3, BCL2, BDNF, BID, BLM, BRCA1, BRCA2, BRF1, BUB1B, CAB39, CAMK2A, CAMP, CAPN1, CASP10, CASP12, CASP3, CASP7, CASP8, CASP9, CCNA2, CCND1, CCNE1, CD82, CDC25C, CDK2, CDK4, CDKN1A, CDKN1B, CDKN2B, CHEK1, CHEK2, CHUK, CREB1, CREBBP, CRK, CST3, CTNNB1, DAG1, DAXX, DCC, DFFA, DFFB, E2F1, E2F4, EGF, EGFR, EGR1, EIF2AK2, EP300, ERBB2, ESR1, ESR2, EZH2, FADD, FAS, FASLG, FGF1, FGF2, FGFR1, FKBP1A, FKBP1B, FKBP3, FST, FTL, GADD45A, GPRC5A, GRB2, GSK3A, GTF2A2, HDAC8, HNF4A, HPGDS, HSP90AB1, IAPP, IGF1, IGFBP3, IL11, IL1R1, IL3, INHBA, JUN, JUNB, JUND, KRAS, LEFTY1, LIG1, LTBP1, MAP2K1, MAP3K4, MAP3K5, MAPK1, MAPK14, MAPK3, MAPK4, MAPK7, MAPK8, MAPK9, MAPT, MDM2, MIR21, MNAT1, MRE11A, MST1, MYC, MYT1, NCK1, NFKB1, NFKBIA, NME1, NODAL, NOXA1, NT5C1A, NTF3, NTRK1, PAK1, PCNA, PDGFA, PDGFRA, PDK1, PIAS1, PIK3CA, PITX2, PLA2G4A, PLK1, PLN, PML, POLA1, POLR1A, PPP1R13L, PRKAA2, PRKCA, PTEN, PTGS2, PTTG1, RAC1, RAD50, RAD51, RAD52, RAF1, RAP1A, RAPGEF3, RARA, RARB, RB1CC1, RBL1, RHEB, RRM1, RXRA, SERPINB10, SHH, SIRT1, SMAD2, SMAD4, SMAD6, SMO, SOS1, SP1, SRC, STAT1, STAT5A, STK11, STMN1, TBP, TFF1, TGFB1, TGFBR1, THBS1, TNF, TNFRSF1A, TOP1, TOP2A, TP53, TP53BP2, TRAF2, TYMS, VEGFA, WRN, WT1]	TRUE
WP:2380	WikiPathways_09.11.2015	BDNF signaling pathway	[-1]	[Group1, Group10, Group13, Group29, Group31, Group33, Group34, Group35, Group4, Group41, Group46, Group47, Group48, Group52, Group57]	4	2.7777777	0.08793162131592586	1.0	{Group1=0.3422234010584369, Group10=0.015320357032764444, Group13=0.33292187912560667, Group29=0.03040812164679128, Group31=0.18555280111792985, Group33=0.013749297939086429, Group34=0.023242299876161884, Group35=0.3257975894079523, Group4=2.3359082094591414E-6, Group41=0.11610019037275422, Group46=0.013359738966869447, Group47=0.005968472152834779, Group48=0.10903713332925667, Group52=0.12732028864491843, Group57=2.7626465873397032E-5}	{Group1=1.0, Group10=0.6281346383433422, Group13=1.0, Group29=1.0, Group31=1.0, Group33=0.57747051344163, Group34=0.9296919950464754, Group35=1.0, Group4=1.4949812540538505E-4, Group41=1.0, Group46=0.5744687755753862, Group47=0.26858124687756507, Group48=1.0, Group52=1.0, Group57=0.001685214418277219}	[CREB1, HRAS, MTOR, PRKAA1]	[ACACB, ADAM17, AKT1, ALPL, APC, BAD, BCL2L11, BDNF, BMP2, CAMK1, CAMK2A, CAMK4, CASP3, CDC42, CDH2, CDK5, CDK5R1, CDKL5, CFL1, CHUK, CNR1, CREB1, CRTC1, CSNK2A1, CTNNB1, CYFIP1, DLG1, DOCK3, DOK5, DPYSL2, EEF2, EGR1, EGR2, EIF2S1, EIF2S2, EIF4E, EIF4EBP1, ELK1, FOS, FOXO3, FRS2, FRS3, FYN, GABRB3, GNB2L1, GRB2, GRIA1, GRIA2, GRIA3, GRIN1, GRIN2B, GRIP1, GSK3B, HRAS, IGF2BP1, IKBKB, IKBKG, IRS1, IRS2, JAK2, JUN, KCNA3, KCNN2, KIDINS220, KSR1, LINGO1, MAP2K1, MAP2K2, MAP2K5, MAP3K1, MAP3K2, MAPK1, MAPK10, MAPK14, MAPK3, MAPK7, MAPK8, MAPK9, MAPT, MARCKS, MEF2A, MEF2C, MTOR, NCAM1, NCF1, NCF2, NCK1, NCK2, NFATC4, NFKB1, NFKBIA, NGF, NGFR, NSF, NTF3, NTRK1, NTRK2, NTRK3, PDPK1, PIK3R1, PIK3R2, PLCG1, PPP2CA, PRKAA1, PRKAA2, PRKCD, PTK2B, PTPN11, PTPRF, RAB3A, RAC1, RAF1, RANBP9, RAP1A, RASGRF1, RELA, RHOG, RPS6, RPS6KA1, RPS6KA3, RPS6KA5, RPS6KB1, SH2B1, SH2B2, SHC1, SHC2, SHC3, SHC4, SIRPA, SORT1, SPP1, SQSTM1, SRC, STAT1, STAT3, STAT5A, STAT5B, SYN1, TIAM1, TRAF6, TSC2, VAV2, VAV3, YBX1]	FALSE
WP:2431	WikiPathways_09.11.2015	Spinal Cord Injury	[-1]	[Group50, Group54, Group56, Group71, Group74, Group76]	1	0.84745765	1.0	1.0	{Group50=0.3398859873930151, Group54=0.2887596066788072, Group56=0.3398859873930151, Group71=0.257855130160565, Group74=0.5483333906310934, Group76=0.4084685652197573}	{Group50=1.0, Group54=1.0, Group56=1.0, Group71=1.0, Group74=1.0, Group76=1.0}	[PPP3CA]	[ACAN, AIF1, ANXA1, APEX1, AQP1, AQP4, ARG1, BCAN, BDNF, BTG2, C1QB, C5, CASP3, CCL2, CCND1, CCNG1, CCR2, CD47, CDC42, CDK1, CDK2, CDK4, CDKN1B, CHST11, COL2A1, COL4A1, CSPG4, CXCL1, CXCL10, CXCL2, CXCL8, E2F1, E2F5, EFNB2, EGFR, EGR1, EPHA4, FCGR2A, FCGR2C, FKBP1A, FOS, FOXO3, GADD45A, GAP43, GDNF, GFAP, GJA1, GRIN1, ICAM1, IFNG, IL1A, IL1B, IL1R1, IL2, IL4, IL6, KLK8, LEP, LGALS3, LILRB2, LILRB3, LOC102725035, LTB, LTB4R, MAG, MAPK1, MAPK3, MBP, MIF, MIR23B, MMP9, MYC, NCAN, NGFR, NOS1, NOS2, NOX4, NR4A1, NTN1, OMG, PDYN, PLA2G2A, PLA2G5, PLA2G6, PLXNA2, PPP3CA, PRB1, PRKCA, PTGS2, PTPRA, PTPRZ1, RAC1, RB1, RGMA, RHOA, RHOB, RHOC, ROCK2, ROS1, RTN4, RTN4R, SELP, SEMA6A, SLIT1, SLIT2, SLIT3, SOX9, TACR1, TGFB1, TLR4, TNF, TNFSF13, TNFSF13B, TP53, VCAN, VIM, XYLT1, ZFP36]	TRUE
WP:2446	WikiPathways_09.11.2015	Retinoblastoma (RB) in Cancer	[-1]	[Group49]	5	5.681818	0.0034976682445137346	0.29030646429463997	{Group49=0.0034976682445137346}	{Group49=0.16439040749214553}	[ABL1, MSH6, POLE, PRKDC, RRM1]	[ABL1, ANLN, BARD1, CCDC6, CCNA2, CCNB1, CCNB2, CCND1, CCND3, CCNE1, CCNE2, CDC25A, CDC25B, CDC45, CDC7, CDK1, CDK2, CDK4, CDK6, CDKN1A, CDKN1B, CDT1, CHEK1, DCK, DHFR, DNMT1, E2F1, E2F2, E2F3, FAF1, FANCG, H2AFZ, HDAC1, HLTF, HMGB1, HMGB2, KIF4A, MAPK13, MCM3, MCM4, MCM6, MCM7, MDM2, MIR21, MSH6, MYC, NPAT, ORC1, PCNA, PLK4, POLA1, POLD3, POLE, POLE2, PRIM1, PRKDC, PRMT2, RABIF, RAF1, RB1, RBBP4, RBBP7, RBP1, RFC3, RFC4, RFC5, RPA1, RPA2, RPA3, RRM1, RRM2, SAP30, SIN3A, SKP2, SMARCA2, SMC1A, SMC2, SMC3, STMN1, SUV39H1, TFDP1, TFDP2, TOP2A, TP53, TTK, TYMS, WEE1, ZNF655]	TRUE
WP:2447	WikiPathways_09.11.2015	Amyotrophic lateral sclerosis (ALS)	[-1]	[Group50, Group54, Group56, Group71, Group75, Group76]	2	5.263158	0.07288533135133482	1.0	{Group50=0.3398859873930151, Group54=0.2887596066788072, Group56=0.3398859873930151, Group71=0.257855130160565, Group75=0.12156046396649858, Group76=0.4084685652197573}	{Group50=1.0, Group54=1.0, Group56=1.0, Group71=1.0, Group75=1.0, Group76=1.0}	[BID, PPP3CA]	[ALS2, APAF1, BAD, BAX, BCL2, BCL2L1, BID, CASP1, CASP12, CASP3, CASP9, CAT, CCS, CST3, DAXX, DERL1, GPX1, GRIA1, MAP2K2, MAP2K6, MAP3K5, MAPK14, NEFH, NEFL, NEFM, NOS1, PPP3CA, PPP3CB, PPP3CC, PRPH, RAB5A, RAC1, SLC1A2, SOD1, TNF, TNFRSF1A, TOMM40, TP53]	TRUE
WP:2516	WikiPathways_09.11.2015	ATM Signaling Pathway	[-1]	[Group17, Group25, Group30, Group51, Group6, Group61]	7	17.948717	2.4386852870739256E-7	2.6337801100398395E-5	{Group17=6.776241579089485E-11, Group25=0.0014192920911883721, Group30=2.972243278064436E-11, Group51=5.751852119082846E-12, Group6=0.0018572031677458632, Group61=3.758262700808551E-9}	{Group17=4.607844273780849E-9, Group25=0.0766417729241721, Group30=2.080570294645105E-9, Group51=4.083815004548821E-10, Group6=0.09843176789053075, Group61=2.518036009541729E-7}	[ABL1, ATM, BID, BRCA1, CREB1, RAD50, RAD51]	[ABL1, AP3B2, ATF2, ATM, BID, BRCA1, CASP2, CCNB1, CDC25A, CDC25C, CDK1, CDK2, CDKN1A, CHEK1, CHEK2, CRADD, CREB1, FANCD2, GADD45A, H2AFX, IKBKG, JUN, MAPK9, MDC1, MDM2, MDM4, MRE11A, NBN, NFKBIA, PIDD1, RAD50, RAD51, RAD9A, RIPK1, SMC1A, TLK1, TP53, TP53BP1, TP73]	TRUE
WP:2526	WikiPathways_09.11.2015	PDGF Pathway	[-1]	[Group1, Group12, Group20, Group27, Group41, Group48]	1	2.5641026	0.3705393207519536	1.0	{Group1=0.3422234010584369, Group12=0.2420215438602354, Group20=4.853337156445499E-4, Group27=0.003150245716997155, Group41=0.11610019037275422, Group48=0.10903713332925667}	{Group1=1.0, Group12=1.0, Group20=0.028149355507383896, Group27=0.15751228584985774, Group41=1.0, Group48=1.0}	[HRAS]	[ARFIP2, CDC42, CHUK, COX2, ELK1, FOS, GRB2, HRAS, JAK1, JUN, MAP2K1, MAP2K4, MAP3K1, MAPK1, MAPK3, MAPK8, NFKBIA, PAK1, PDGFA, PDGFB, PDGFRB, PIK3R1, PLA2G4A, PLCG1, PTPN11, RAC1, RAF1, RASA1, RHOA, SHC1, SOS1, SRC, SRF, STAT1, STAT3, TIAM1, VAV1, VAV2, WASL]	FALSE
WP:2572	WikiPathways_09.11.2015	Primary Focal Segmental Glomerulosclerosis FSGS	[-1]	[Group27, Group32, Group67]	2	2.739726	0.21142096555124715	1.0	{Group27=0.003150245716997155, Group32=0.04886948215445072, Group67=0.11782420498332685}	{Group27=0.15751228584985774, Group32=1.0, Group67=1.0}	[MKI67, PTK2]	[ACTN4, AGRN, AKT1, CAMK2B, CD151, CD2AP, CD80, CDH2, CDKN1A, CDKN1B, CDKN1C, CLDN1, COL4A3, COL4A4, COL4A5, CR1, CTNNB1, CTSL, DAG1, DKK1, DNM1, FAT1, FYN, ILK, INF2, IRF6, ITGA3, ITGAV, ITGB1, ITGB3, ITGB4, JAG1, KIRREL2, KIRREL3, KRT8, LAMA5, LAMB2, LIMS1, LIMS3L, LMX1B, LRP5, LRP6, MKI67, MME, MYH9, MYO1E, NCK1, NOTCH1, NPHS1, NPHS2, PARVA, PAX2, PCNA, PLAUR, PLCE1, PLCG1, PODXL, PTK2, PTPRO, SCARB2, SMARCAL1, SYNPO, TGFB1, TLN1, TLR4, TRPC6, UTRN, VCL, VIM, VTN, WNT1, WT1, YWHAQ]	TRUE
WP:2583	WikiPathways_09.11.2015	T-Cell Receptor and Co-stimulatory Signaling	[-1]	[Group50, Group54, Group56, Group71, Group76]	2	7.142857	0.04219987992037855	1.0	{Group50=0.3398859873930151, Group54=0.2887596066788072, Group56=0.3398859873930151, Group71=0.257855130160565, Group76=0.4084685652197573}	{Group50=1.0, Group54=1.0, Group56=1.0, Group71=1.0, Group76=1.0}	[PPP3CA, PTEN]	[AKT1, CALM1, CD28, CD8A, CD8B, CSNK1A1, CTLA4, DYRK1A, DYRK2, FYN, GSK3A, GSK3B, IL2, ITK, LCK, NFATC2, NFKB1, NFKBIA, PDCD1, PDK1, PLCG1, PPP3CA, PRKCA, PTEN, PTPN6, RASA1, RASGRP1, ZAP70]	FALSE
WP:2586	WikiPathways_09.11.2015	Aryl Hydrocarbon Receptor	[-1]	[Group11, Group12, Group15, Group18, Group20, Group37, Group46, Group53, Group57, Group68, Group74]	3	6.521739	0.01634648586252899	1.0	{Group11=0.0020227372439293166, Group12=0.2420215438602354, Group15=5.47972669334322E-4, Group18=2.2676648782666833E-5, Group20=4.853337156445499E-4, Group37=7.113870981722735E-7, Group46=0.013359738966869447, Group53=6.567096321826248E-4, Group57=2.7626465873397032E-5, Group68=3.328030031465086E-4, Group74=0.5483333906310934}	{Group11=0.10518233668432446, Group12=1.0, Group15=0.03068646948272203, Group18=0.0014059522245253437, Group20=0.028149355507383896, Group37=4.624016138119778E-5, Group46=0.5744687755753862, Group53=0.036119029770044365, Group57=0.001685214418277219, Group68=0.01963537718564401, Group74=1.0}	[HRAS, KRAS, NRAS]	[AHR, AHRR, AIP, ARNT, CCL1, CD36, CDC37, CDK2, CDKN1A, CDKN1B, CYP1A1, CYP1A2, CYP1B1, E2F1, EGFR, EP300, ESR1, FGF21, GCLC, HPGDS, HRAS, HSP90AA1, KLF6, KRAS, LPL, MAP2K1, MAPK1, MYC, NCOA7, NCOR2, NF1, NFE2L2, NFKB1, NQO1, NRAS, NRIP1, PLAGL1, PSRC1, PTGS2, RAF1, RB1, RELA, RET, SRC, TNF, VEGFA]	TRUE
WP:2643	WikiPathways_09.11.2015	Nanoparticle-mediated activation of receptor signaling	[-1]	[Group11, Group15, Group18, Group20, Group27, Group37, Group4, Group48, Group53, Group57, Group64, Group68, Group74]	4	14.285714	2.845974405396353E-4	0.02845974405396353	{Group11=0.0020227372439293166, Group15=5.47972669334322E-4, Group18=2.2676648782666833E-5, Group20=4.853337156445499E-4, Group27=0.003150245716997155, Group37=7.113870981722735E-7, Group4=2.3359082094591414E-6, Group48=0.10903713332925667, Group53=6.567096321826248E-4, Group57=2.7626465873397032E-5, Group64=1.3778632235359839E-5, Group68=3.328030031465086E-4, Group74=0.5483333906310934}	{Group11=0.10518233668432446, Group15=0.03068646948272203, Group18=0.0014059522245253437, Group20=0.028149355507383896, Group27=0.15751228584985774, Group37=4.624016138119778E-5, Group4=1.4949812540538505E-4, Group48=1.0, Group53=0.036119029770044365, Group57=0.001685214418277219, Group64=8.680538308276698E-4, Group68=0.01963537718564401, Group74=1.0}	[HRAS, KRAS, NRAS, PTK2]	[AKT3, AREG, COL1A1, EGFR, FN1, GRB2, HRAS, ITGA1, ITGB1, KRAS, MAP2K1, MAP2K2, MAPK1, MAPK10, MAPK11, MAPK12, MAPK13, MAPK14, MAPK8, MAPK9, NRAS, PIK3CD, PTK2, PXN, RAF1, SOS1, SRC, TLN1]	TRUE
WP:2795	WikiPathways_09.11.2015	Cardiac Hypertrophic Response	[-1]	[Group0, Group13, Group32, Group36, Group50, Group52, Group54, Group56, Group71, Group72, Group76]	2	3.7037036	0.13198073992097265	1.0	{Group0=0.023577362178657905, Group13=0.33292187912560667, Group32=0.04886948215445072, Group36=0.4341567002016995, Group50=0.3398859873930151, Group52=0.12732028864491843, Group54=0.2887596066788072, Group56=0.3398859873930151, Group71=0.257855130160565, Group72=0.004865643191837814, Group76=0.4084685652197573}	{Group0=0.9195171249676584, Group13=1.0, Group32=1.0, Group36=1.0, Group50=1.0, Group52=1.0, Group54=1.0, Group56=1.0, Group71=1.0, Group72=0.22381958682453945, Group76=1.0}	[MTOR, PPP3CA]	[AKT1, AKT2, CALM1, CAMK2D, CDK7, CDK9, CHUK, EGF, FGF2, FGFR2, GSK3B, GUCA1A, HDAC4, HDAC5, HDAC7, HDAC9, IGF1, IKBKB, IKBKE, IKBKG, MAP2K1, MAP2K2, MAP2K3, MAP2K4, MAP2K5, MAP2K6, MAP2K7, MAP3K1, MAP3K14, MAP3K7, MAP4K1, MAPK1, MAPK14, MAPK3, MAPK7, MAPK8, MEF2A, MTOR, NFATC2, NFKB1, NPPA, NRG1, PDPK1, PLA2G2A, PPP3CA, PRKCA, PRKD1, PRKG1, RAC1, RAF1, TGFB1, TGFBR1, TNF, TNFRSF1A]	FALSE
WP:2804	WikiPathways_09.11.2015	Hair Follicle Development: Induction (Part 1 of 3)	[-1]	[Group8]	1	2.3809524	0.392653099653618	1.0	{Group8=1.0}	{Group8=1.0}	[SMO]	[BMP4, BMPR1A, CDH3, CHUK, CTGF, CTNNB1, DKK4, DVL1, EDA, EDAR, EGF, EGFR, FGF20, FGF7, FGFR1, FGFR2, FOXI3, FST, FZD1, GJB6, GSK3B, IKBKB, INHBA, IVL, KRT10, LEF1, LRP5, LRP6, MSX2, MYC, NFKB1, NFKBIB, NOG, PTCH1, SHH, SMO, SP5, TCF3, TP63, VCAN, WNT10A, WNT10B]	FALSE
WP:2828	WikiPathways_09.11.2015	Bladder Cancer	[-1]	[Group1, Group12, Group20, Group27, Group41, Group48]	1	3.2258065	0.3076285937979914	1.0	{Group1=0.3422234010584369, Group12=0.2420215438602354, Group20=4.853337156445499E-4, Group27=0.003150245716997155, Group41=0.11610019037275422, Group48=0.10903713332925667}	{Group1=1.0, Group12=1.0, Group20=0.028149355507383896, Group27=0.15751228584985774, Group41=1.0, Group48=1.0}	[HRAS]	[BRAF, CCND1, CDH1, CDK4, CDKN1A, CDKN2A, CXCL8, DAPK1, DAPK2, DAPK3, E2F1, EGF, EGFR, ERBB2, FGFR3, HRAS, MAP2K1, MAP2K2, MAPK1, MDM2, MMP1, MYC, PIK3R1, PIK3R2, RASSF1, RB1, RPS6KA5, THBS1, TP53, TYMP, VEGFA]	FALSE
WP:2853	WikiPathways_09.11.2015	Endoderm Differentiation	[-1]	[Group60]	1	1.4492754	0.560245333550186	1.0	{Group60=1.0}	{Group60=1.0}	[EZH2]	[APC, APP, BMP7, BMPR1A, BPTF, CAND1, CDC73, CER1, CTNNB1, CTR9, DAB2, DKK1, DUSP2, DUSP4, DUSP5, ELAVL1, EOMES, EPB41L5, EXT1, EZH2, FOXA1, FOXA2, FOXH1, GATA4, GATA6, GDF3, HHEX, HOXA1, HOXC11, JARID2, LAMC1, LEF1, LEO1, LOC101929777, MAP2K3, MIR141, MIR373, MIXL1, NANOG, NKX2-1, NODAL, NOG, NOTCH1, NR3C1, ONECUT1, OTX2, PABPC1, PAF1, PAX9, POU5F1, PRDM14, PTHLH, RAB38, RTF1, SFRP1, SIAH2, SMAD2, SMAD3, SMAD4, SOX17, SOX2, SOX7, STAT1, TBX21, TCF7, TGFB1, TNRC6C, WNT3, WNT8A]	FALSE
WP:2858	WikiPathways_09.11.2015	Ectoderm Differentiation	[-1]	[Group38]	1	0.7246377	1.0	1.0	{Group38=0.8126859102118735}	{Group38=1.0}	[ABCC4]	[ABCC4, AES, AHI1, ANKS1B, ARHGAP10, ARHGAP15, ARHGDIG, ARHGEF9, ARX, ASTN1, BAZ1A, BCAS3, BCOR, BMP4, BMPR1A, BOC, C1GALT1, CAP2, CCDC130, CCDC88C, CCL2, CDH6, CDH8, CDON, CELSR2, CLDN11, CLVS1, CTBP1, CTNNA2, CTNNB1, CTNND2, DMD, EDA, EDA2R, ELOVL2, ELOVL4, FGFR2, FHL2, FOXA2, FOXL1, FYN, FZD4, FZD5, FZD8, GAS2L1, GATA6, GLB1, GLI3, GRAMD1B, GREB1, HDAC10, HDAC6, HESX1, HIST1H2BH, HMGB2, JAKMIP1, JUP, KCNK10, KIAA1161, KIFC3, KRT6A, LDB2, LY6E, MAFB, MECP2, MIR15B, MKS1, MYC, MZF1, NARS2, NF2, NFATC1, NLGN1, NLK, NR2F2, NUMA1, OGT, PAN2, PAX3, PAX6, PDE7A, PGM1, PHF8, PI4KA, PIM1, PLCXD3, PLXNA2, PODXL, POU2F2, PPARD, PPFIBP2, PRKAG2, PTPN13, PTPRB, RAB8B, RGMA, RHPN1, RIT1, ROR2, RRBP1, SCHIP1, SDCBP, SERPINB6, SGSM3, SHH, SIX6, SKIL, SMAD4, SMURF1, SNCA, SOCS2, SORCS1, SOX2, SPRY2, ST8SIA4, STC1, STX16, TBL1X, TCF3, TCF7L1, TFAP2A, TFAP2C, TNFRSF11B, TOX3, TRIM33, TRPM2, TSC22D1, TSKU, TTC14, UBTF, VAX2, WDR44, WNT1, ZBTB16, ZBTB2, ZBTB7B, ZFHX4, ZNF219]	FALSE
WP:2864	WikiPathways_09.11.2015	Apoptosis-related network due to altered Notch3 in ovarian cancer	[-1]	[Group55]	4	7.5471697	0.003272951444219319	0.2749279213144228	{Group55=0.003272951444219319}	{Group55=0.16037462076674663}	[ABL1, HSPD1, PTK2, TNFRSF10B]	[ABL1, AKT1, ANXA5, APOE, APP, AXIN1, BCL3, BIRC5, CARD14, CASP7, CDKN1A, CDKN1B, CTNNA1, CUL1, CUL5, ERBB3, ERN1, ETS1, F2R, GCLC, HDAC1, HELLS, HSPA5, HSPB1, HSPD1, IER3, IL7R, JUND, MAPK1, NET1, NFKB1, NGFRAP1, NQO1, NRG1, PAK2, PKN1, PTK2, PTK2B, RIPK2, RNF7, RPS6KB1, SERBP1, SMAD7, SOCS3, SQSTM1, THBS1, TNF, TNFRSF10B, TNFRSF21, TRAF1, VAV3, VIM, YBX3]	TRUE
WP:2865	WikiPathways_09.11.2015	IL1 and megakaryotyces in obesity	[-1]	[Group19, Group22, Group36, Group66, Group70]	1	4.1666665	0.24754298117348875	1.0	{Group19=1.0, Group22=0.11196305953800512, Group36=0.4341567002016995, Group66=0.09528179928216532, Group70=0.37553683169036156}	{Group19=1.0, Group22=1.0, Group36=1.0, Group66=1.0, Group70=1.0}	[PIK3CA]	[CCL2, CCR3, F2, F2R, FCER1A, HBEGF, ICAM1, IFNG, IL18, IL1B, IL1R1, IRAK1, MMP9, MYD88, NFKB1, NLRP3, PIK3CA, PLA2G7, S100A9, SELENBP1, TIMP1, TIMP2, TLR1, TLR2]	TRUE
WP:2870	WikiPathways_09.11.2015	Extracellular vesicle-mediated signaling in recipient cells	[-1]	[Group15, Group18, Group20, Group33, Group37, Group4, Group46, Group47, Group48, Group53, Group57, Group68, Group74]	4	13.333333	3.743197459332299E-4	0.036683335101456535	{Group15=5.47972669334322E-4, Group18=2.2676648782666833E-5, Group20=4.853337156445499E-4, Group33=0.013749297939086429, Group37=7.113870981722735E-7, Group4=2.3359082094591414E-6, Group46=0.013359738966869447, Group47=0.005968472152834779, Group48=0.10903713332925667, Group53=6.567096321826248E-4, Group57=2.7626465873397032E-5, Group68=3.328030031465086E-4, Group74=0.5483333906310934}	{Group15=0.03068646948272203, Group18=0.0014059522245253437, Group20=0.028149355507383896, Group33=0.57747051344163, Group37=4.624016138119778E-5, Group4=1.4949812540538505E-4, Group46=0.5744687755753862, Group47=0.26858124687756507, Group48=1.0, Group53=0.036119029770044365, Group57=0.001685214418277219, Group68=0.01963537718564401, Group74=1.0}	[HRAS, KRAS, MTOR, NRAS]	[AKT1, APC, AXIN1, CTNNB1, DKK4, EGFR, ERBB2, HGF, HRAS, KRAS, MET, MFGE8, MTOR, NRAS, PIK3R5, PROM1, RAF1, SMAD2, SMAD3, SMAD4, TGFA, TGFB1, TGFB2, TGFB3, TGFBR1, TGFBR2, TGFBR3, TSPAN8, WNT3A, WNT5A]	TRUE
WP:2875	WikiPathways_09.11.2015	Constitutive Androstane Receptor Pathway	[-1]	[Group24, Group38, Group63]	1	3.125	0.3158180874997565	1.0	{Group24=0.7890042018472335, Group38=0.8126859102118735, Group63=0.296656766532177}	{Group24=1.0, Group38=1.0, Group63=1.0}	[ABCB1]	[ABCB1, ABCC2, ABCC3, ALAS1, CYP2A6, CYP2B6, CYP2C19, CYP2C9, CYP3A4, CYP3A5, CYP4A11, DNAJC7, EHHADH, FOXO1, GSTA2, HSP90AA1, NCOA1, NCOA2, NCOA6, NR1I3, PPARGC1A, PPP2R4, RXRA, SMC1A, SP1, SULT1A1, SULT2A1, UGT1A1, UGT1A3, UGT1A4, UGT1A6, UGT1A9]	FALSE
WP:2878	WikiPathways_09.11.2015	PPAR Alpha Pathway	[-1]	[Group31, Group43, Group58, Group63]	1	3.8461537	0.26521440862673307	1.0	{Group31=0.18555280111792985, Group43=0.27638591509599, Group58=0.04294071628232707, Group63=0.296656766532177}	{Group31=1.0, Group43=1.0, Group58=1.0, Group63=1.0}	[PPARA]	[ACAA1, ACADM, APOA1, APOA2, APOA5, APOC3, CCND1, CDK1, CDK4, CPT1A, CPT2, CYP4A11, CYP7A1, CYP8B1, DBI, EHHADH, FABP1, KLK15, MYC, NR1H3, PLTP, PPARA, RXRA, SCP2, SLC27A1, UGT1A9]	FALSE
WP:2881	WikiPathways_09.11.2015	Estrogen Receptor Pathway	[-1]	[Group31, Group43, Group58, Group63]	1	7.6923075	0.1426250929324131	1.0	{Group31=0.18555280111792985, Group43=0.27638591509599, Group58=0.04294071628232707, Group63=0.296656766532177}	{Group31=1.0, Group43=1.0, Group58=1.0, Group63=1.0}	[PPARA]	[ACOX1, CYP1A1, CYP1A2, CYP1B1, ESR1, GPAM, JUN, NR0B2, PCK1, PDK4, PPARA, SP1, STAT3]	FALSE
WP:2884	WikiPathways_09.11.2015	NRF2 pathway	[-1]	[Group38]	2	1.3793104	0.6880653785116109	1.0	{Group38=0.8126859102118735}	{Group38=1.0}	[ABCC4, HSP90AB1]	[ABCC2, ABCC3, ABCC4, ABCC5, ADH7, AGER, ALDH3A1, BLVRB, CBR1, CBR3, CES1, CES2, CES3, CES4A, CES5A, CYP2A6, CYP4A11, DNAJB1, EGR1, EPHA2, EPHA3, FGF13, FTH1, FTL, G6PD, GCLC, GCLM, GGT1, GGT2, GGTLC1, GGTLC2, GPX2, GPX3, GSR, GSTA1, GSTA2, GSTA3, GSTA4, GSTA5, GSTM1, GSTM2, GSTM3, GSTM4, GSTM5, GSTP1, GSTT2, HBEGF, HGF, HMOX1, HSP90AA1, HSP90AB1, HSPA1A, KEAP1, LOC102724197, MAFF, MAFG, ME1, MGST2, MGST3, NFE2L2, NQO1, NRG1, PDGFB, PGD, PPARD, PRDX1, PRDX6, PTGR1, RXRA, SERPINA1, SLC2A1, SLC2A10, SLC2A11, SLC2A12, SLC2A13, SLC2A14, SLC2A2, SLC2A3, SLC2A4, SLC2A5, SLC2A6, SLC2A7, SLC2A8, SLC2A9, SLC39A1, SLC39A10, SLC39A11, SLC39A12, SLC39A13, SLC39A14, SLC39A2, SLC39A3, SLC39A4, SLC39A5, SLC39A6, SLC39A7, SLC39A8, SLC39A9, SLC5A1, SLC5A10, SLC5A11, SLC5A12, SLC5A2, SLC5A3, SLC5A4, SLC5A5, SLC5A6, SLC5A7, SLC5A8, SLC5A9, SLC6A1, SLC6A11, SLC6A13, SLC6A15, SLC6A16, SLC6A17, SLC6A18, SLC6A19, SLC6A2, SLC6A20, SLC6A3, SLC6A4, SLC6A5, SLC6A6, SLC6A7, SLC6A8, SLC6A9, SLC7A11, SOD3, SQSTM1, TGFA, TGFB1, TGFB2, TGFBR2, TXN, TXNRD1, TXNRD3, TXNRD3NB, UGT1A1, UGT1A3, UGT1A4, UGT1A6, UGT1A7, UGT1A9, UGT2B7]	FALSE
WP:2916	WikiPathways_09.11.2015	Interactome of polycomb repressive complex 2 (PRC2) 	[-1]	[Group60]	1	6.25	0.17258577446938866	1.0	{Group60=1.0}	{Group60=1.0}	[EZH2]	[AEBP2, BCLAF1, EED, ELL, EZH1, EZH2, JARID2, MORC3, MTF2, RBBP4, RBBP7, SETX, STK38, SUZ12, THRAP3, TRIM35]	FALSE
WP:2942	WikiPathways_09.11.2015	DDX1 as a regulatory component of the Drosha microprocessor	[-1]	[Group28, Group51, Group61, Group69]	2	28.571428	0.002744283195167378	0.23326407158922713	{Group28=3.1293743276319113E-11, Group51=5.751852119082846E-12, Group61=3.758262700808551E-9, Group69=0.006439583968393921}	{Group28=2.159268286066019E-9, Group51=4.083815004548821E-10, Group61=2.518036009541729E-7, Group69=0.2833416946093325}	[ATM, RAD50]	[ATM, DDX1, DGCR8, DROSHA, MRE11A, NBN, RAD50]	TRUE
WP:2946	WikiPathways_09.11.2015	Imatinib Resistance in Chronic Myeloid Leukemia	[-1]	[Group62]	4	8.163265	0.0024520173394183093	0.21332550852939292	{Group62=0.0024520173394183093}	{Group62=0.1250528843103338}	[ABCB1, ABCG2, ABL1, FLT1]	[ABCB1, ABCG2, ABL1, ANXA2R, BBX, BCL11A, BCR, CASZ1, CCND3, CDK6, CDKN1B, CPEB4, CSF1R, EPO, FLT1, FOXO3, GAB1, GAB2, GADD45A, HMGB2, IGF2BP1, KIT, LYL1, LYN, MAP2K6, MAVS, MYC, NOL4L, NOP2, NSD1, PDGFRA, PDGFRB, PEX14, PIM1, PIM2, PRKACA, PTP4A2, PVT1, RAB36, RPS6KA1, SKP2, SLC4A10, SLC4A7, SLC50A1, SLC7A3, SPRED1, SPRED2, TRIM28, ZC3HAV1]	TRUE
WP:3286	WikiPathways_09.11.2015	Copper homeostasis	[-1]	[Group10, Group22, Group64, Group66]	3	5.5555553	0.025009690433550197	1.0	{Group10=0.015320357032764444, Group22=0.11196305953800512, Group64=1.3778632235359839E-5, Group66=0.09528179928216532}	{Group10=0.6281346383433422, Group22=1.0, Group64=8.680538308276698E-4, Group66=1.0}	[ATP7A, PIK3CA, PTEN]	[ADAM10, ADAM17, ADAM9, AKT1, APC, APP, ATOX1, ATP7A, ATP7B, BACE1, CASP3, CCND1, CCS, COMMD1, COX11, COX17, FOXO1, FOXO3, GSK3B, JUN, MAPT, MDM2, MT1A, MT1B, MT1E, MT1F, MT1G, MT1H, MT1JP, MT1L, MT1X, MT2A, MT3, MT4, MTF1, MTF2, PIK3CA, PRNP, PTEN, SCO1, SCO2, SLC11A2, SLC31A1, SLC31A2, SOD1, SOD3, SP1, STEAP1, STEAP2, STEAP3, STEAP4, TP53, XAF1, XIAP]	FALSE
WP:3301	WikiPathways_09.11.2015	MFAP5-mediated ovarian cancer cell motility and invasiveness	[-1]	[Group27, Group32, Group48, Group67, Group70]	1	8.333333	0.1324033046661801	1.0	{Group27=0.003150245716997155, Group32=0.04886948215445072, Group48=0.10903713332925667, Group67=0.11782420498332685, Group70=0.37553683169036156}	{Group27=0.15751228584985774, Group32=1.0, Group48=1.0, Group67=1.0, Group70=1.0}	[PTK2]	[CREB5, ITGAV, ITGB3, ITPR3, JUN, MAPK1, MFAP5, PLCG1, PRKCQ, PTK2, RYR3, TNNC1]	FALSE
WP:3303	WikiPathways_09.11.2015	Rac1/Pak1/p38/MMP-2 pathway	[-1]	[Group11, Group15, Group18, Group20, Group27, Group37, Group53, Group57, Group64, Group68]	7	10.606061	9.661220862028756E-6	0.0010047669696509906	{Group11=0.0020227372439293166, Group15=5.47972669334322E-4, Group18=2.2676648782666833E-5, Group20=4.853337156445499E-4, Group27=0.003150245716997155, Group37=7.113870981722735E-7, Group53=6.567096321826248E-4, Group57=2.7626465873397032E-5, Group64=1.3778632235359839E-5, Group68=3.328030031465086E-4}	{Group11=0.10518233668432446, Group15=0.03068646948272203, Group18=0.0014059522245253437, Group20=0.028149355507383896, Group27=0.15751228584985774, Group37=4.624016138119778E-5, Group53=0.036119029770044365, Group57=0.001685214418277219, Group64=8.680538308276698E-4, Group68=0.01963537718564401}	[HRAS, KRAS, MSH2, NRAS, PIK3CA, PTK2, RAD51]	[AKT1, ANGPT1, ANGPT2, ANGPT4, ANGPTL1, BAD, BAX, BIRC5, CASP7, CASP9, CHUK, CRK, CTNNB1, DOK2, EGFR, EIF4EBP1, ERBB2, FN1, FOXO1, GRB14, GRB2, GRB7, HRAS, IKBKB, ITGB1, KRAS, MAPK1, MAPK11, MAPK12, MAPK13, MAPK14, MAPK3, MAPK8, MAPK9, MSH2, MYC, NCK1, NFKB1, NFKBIA, NOS1, NOS2, NRAS, PAK1, PIK3CA, PIK3R1, PTK2, PTPN11, PXN, RAC1, RAD51, RASA1, RELA, RS1, SOS1, SRC, STAT3, STAT5A, STAT5B, STMN1, TEK, TIE1, TNIP1, TNIP2, TNIP3, TP53, YAP1]	TRUE
WP:3414	WikiPathways_09.11.2015	Initiation of transcription and translation elongation at the HIV-1 LTR	[-1]	[Group50, Group54, Group56, Group71, Group74, Group76]	1	3.125	0.3158180874997565	1.0	{Group50=0.3398859873930151, Group54=0.2887596066788072, Group56=0.3398859873930151, Group71=0.257855130160565, Group74=0.5483333906310934, Group76=0.4084685652197573}	{Group50=1.0, Group54=1.0, Group56=1.0, Group71=1.0, Group74=1.0, Group76=1.0}	[PPP3CA]	[CCNT1, CDK9, CREBBP, EP300, HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC7, HDAC8, HDAC9, HEXIM1, NELFA, NELFB, NELFCD, NELFE, NFATC1, NFATC2, NFATC3, NFATC4, NFKB1, NFKBIA, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, RELA, SP1, SUPT4H1, SUPT5H]	FALSE
WP:3527	WikiPathways_09.11.2015	Preimplantation Embryo	[-1]	[Group16]	1	1.754386	0.49227169951343247	1.0	{Group16=1.0}	{Group16=1.0}	[PBX1]	[AQP3, AQP9, ARGFX, ATP1A1, BARX2, BATF3, CDH1, CDX2, CELF3, DDIT3, DLX2, DNMT3L, DPPA3, DPRX, E2F5, EGR1, ELAVL1, ESRRA, FOSB, FOXD1, FOXQ1, GATA2, GATA3, H2AFY2, HMGA1, HNRNPAB, IRF4, IRX5, KHSRP, KLF4, LEUTX, MIR302A, MOS, MTA3, MXD1, MYBL1, NANOG, NANOGNB, NKX2-1, NLRP5, NR3C2, PBX1, SIX3, SMARCA4, SOX11, SOX2, SOX8, TBX3, TCF7L1, TEAD4, TFAP2B, TPRX1, ZAR1, ZFP36, ZFP36L2, ZFP42, ZSCAN4]	FALSE
